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Abstract
The NF-NB repressing factor (NRF) was proposed to act as inhibitor in some NF-NB
regulated promoters. NRF was shown to have inhibitory effects on IFN-E, human iNOS and 
IL-8 promoters. These studies were carried out in established cell lines. To investigate the 
physiological function of NRF in vivo, technology of homologous recombination in mouse ES 
cells followed by injection into a blastocysts was applied and mice lacking NRF protein were 
created. NRF-KO mice are viable, appear phenotypically normal and exhibit normal life 
spans.
To elucidate the effects of NRF protein deletion on the molecular level different cell types 
lacking NRF expression were established and analysed. In none of tested cells the expected 
expression of the cytokine genes (IFN-E and iNOS) was detected in the non-induced state. 
To examine a possible compensation of the lack of NRF during embryonal development a 
method for gene deletion in primary cells was established. Efficient infection was done with a 
retrovirus that leads to constitutive expression of GFP-Cre fusion protein. Homogenous 
population of NRF-deleted cells was obtained by cell sorting shortly after infection. This 
sudden deletion of the NRF gene did not provoke an induction of the IFN-E promoter. The 
presence of one or more factors that function on the inhibition of constitutive activity of this 
cytokine to rapidly compensate the lack of NRF is proposed. 
However the expression of numerous genes affected by changes in NRF expression was 
determined by gene expression profiling. The numerous genes which expression was affected 
belong to different function groups and are involved in various cellular processes like 
apoptosis and immune response. 
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1. Introduction
1.1 Nuclear factor kappa B (NF-NB)
For their survival, all organisms have developed endogenous mechanisms to respond to 
different kinds of stress. These stress responses are closely linked to various signal 
transduction pathways so that the expression of a wide spectrum of proteins related to survival 
of the organism are effectively controlled. NF-NB has been identified as one of the critical 
transcription factors required for expression of genes regulating inflammation, proliferation 
and cell death. Transcription of pro-inflammatory molecules such as the cytokines TNF-D,
IFN-D/E, IL-1, IL-2, IL-6, IL-12, LTD/E and GM-CSF, the chemokines IL-8, RANTES, MIP-
1D, MCP1 and endotoxin, the adhesion molecules ICAM-1, VCAM, E-selectin, the acute 
phase proteins (SAA) and pro-inflammatory enzymes like iNOS (inducible nitric oxide 
synthase), haem oxygenase, cyclooxygenase-2 (COX-2) and xanthine dehydrogenase are 
regulated by NF-NB. First described in 1986 as a nuclear factor necessary for immunoglobulin 
N light chain transcription in B cells (Sen and Baltimore, 1986), NF-NB is known to exist in 
virtually all cell types (Ghosh and Karin, 2002). 
NF-NB proteins
NF-NB are heterodimers that monomers belong to a family of related proteins. There are five 
NF-NB/REL genes, NF.B1, NF.B2, REL-A, c-REL and RELB, that give rise to the 
proteins: REL-A (p65), NF-NB1 (p50, p105), NF-NB2 (p52, p100), c-REL and REL-B. These 
proteins have a structurally conserved amino-terminal 300-amino-acid region, which contains 
the domain responsible for dimerization, nuclear-localization and DNA-binding. The c-REL, 
REL-B and REL-A proteins also have a carboxy-terminal but non-homologous transactivation 
domain, which strongly activates transcription from NF-NB-binding sites in target genes. The 
other REL proteins, such as p50, lack the transactivation domain, but they still bind to NF-NB
consensus sites in DNA and, therefore, function as transcriptional repressors (May and Ghosh, 
1997). The p50 and p52 proteins are generated by proteolytic processing of precursor p105 
and p100 proteins, respectively. Each NF-NB/REL-family member participates in the 
formation of different homo- or heterodimers with another family member. The predominant 
activated form of NF-NB is a heterodimer composed of the p65 subunit associated with either 
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a p50 or a p52 subunit. Whereas p50 and p65 are expressed widely in various cell types, the 
expression of REL-B is restricted to specific regions of the thymus and lymph nodes. The 
expression of c-REL is confined to haematopoietic cells and lymphocytes. 
Genes that encode all five members of the NF-NB family have been deleted by homologous 
recombination in mice (Gerondakis et al, 1999). These gene-knockout animal models indicate 
the distinct roles of the NF-NB proteins in the regulation of innate and adaptive immune 
responses, lymphocyte function and cell survival (Li and Verma, 2002; table 1.1). Mice that 
lack more than one member of the NF-NB family (p50-/-RelB-/- and p50-/-p52-/-) have more 
severe phenotypes, which indicates that there is functional redundancy between the NF-NB
family members. 
Mutated gene 
product
Phenotype in knockout mice 
p65 (Rel-A) 
Die at E15.5–E16.5; TNF-dependent liver apoptosis; defect in 
lymphocyte activation 
NF-NB1 (both 
p105 and p50) 
Survival to adulthood; defect in lymphocyte activation 
NF-NB2 (both 
p100 and p52) 
Survival to adulthood; no mature B cells and defect in lymphocyte 
activation; disruption of splenic and lymph-node architecture 
Rel-B
Die postnatally from multi-organ inflammation; required for dendritic 
cell development 
c-Rel
No developmental defects; defects in lymphocyte and macrophage 
functions
p65 and NF-NB1 Die at E13.5–E14.5 
NF-NB1 and NF-
NB2
Die postnatally; lack mature B cells and osteoblasts 
NF-NB1 and Rel-B Die postnatally owing to immune deficiency 
Table 1.1. Phenotype of knockout mice for NF-țB signalling components (Li and Verma, 
2002).
INB proteins 
NF-NB proteins exist in the cytoplasm in an inactive form as a result of their association with 
the INB proteins of which the most common are INBD, INBE and INBH (Ghosh et al, 1998). In 
the cytoplasm, NF-NB is effectively sequestered by INB in an inactive state via the ability of 
INB to mask the NLS of NF-NB. NF-NB activators induce rapid degradation of INB. This 
activation event is triggered by phosphorylation of INB by the INB kinases (IKK). 
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Phosphorylated INB undergoes polyubiquitination and is then degraded. Degradation of INB
exposes the NLS on NF-NB, which is then translocated to the nucleus.
Activation of the NF-NB
NF-NB is activated by a range of stimuli, including various pro-inflammatory cytokines, stress 
signals and pathogens (Ghosh and Karin, 2002). The activation of NF-NB upon bacterial or 
viral infection is a particularly effective way of initiating an immune response to the infection. 
Since NF-NB pre-exists in the cell and can be stimulated without new protein synthesis, its 
activation occurs quickly. The activation of NF-NB promotes then the synthesis of many 
important immune system regulators. Bacterial and viral products such as LPS and dsRNA as 
well as the transactivating proteins of Herpes Simplex Virus, human T Cell Leukaemia Virus 
(HTLV-1), HIV-1 and Hepatitis B Virus activate NF-NB (Kopp and Ghosh, 1995). Regarding 
the induction of NF-NB by cytokines NF-NB is critically positioned in a network of cytokines 
involved in immune system function. Several cytokines induce NF-NB and many cytokines 
are induced by NF-NB thus establishing an autoregulatory feedback loop. The main cytokines 
known to induce NF-NB are TNF-D and IL-1 (Grilli et al, 1993; Beg et al, 1993).
The NF-NB signalling pathway is schematically presented and shortly described in Figure 1.2. 
Many pathogens are recognized by specific pattern-recognition receptors (PRRs). The best 
known PRRs are the Toll-like receptors (TLRs), a group of transmembrane proteins that 
mediate the activation of intracellular signalling pathways after recognizing extracellular 
pathogens. TLR2 and TLR4 are essential for the recognition of distinct bacterial cell-wall 
components like LPS. IL-1 activates NF-NB in a similar manner as LPS because of the 
homology between the cytoplasmic signalling domains of the IL-1 receptor and the TLRs. 
TNF-D acts via its own receptors that are present on the surface of a wide range of cells. The 
most important event in the activation of NF-NB is the phosphorylation of INBs, which is 
mediated by IKKs. The IKK complex is a converging point for the activation of NF-NB by a 
large number of stimuli. IKK mediated phosphorylation and degradation of INBs promotes 
rapid translocation of the NF-NB complex into the nucleus, where NF-NB influences the 
transcription of target genes. NF-NB induces effectors of immune, inflammatory, or acute 
phase responses. In particular, numerous genes encoding cytokines/growth factors/ 
chemokines, biological messengers that control and coordinate the function of various cells, 
are responsive to NF-NB (Table 1.3). 
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Figure 1.2. NF-NB activation pathways. NF-NB activity is stimulated by many pathways, 
including lipopolysaccharide (LPS), tumour-necrosis factor (TNF) and T-cell receptor (TCR) 
signalling. The inhibitor of NF-NB (INB) kinase (IKK) complex — composed of the kinases 
IKK1 and IKK2 and the regulatory subunit NF-NB essential modulator (NEMO; also known 
as IKKJ) — is a point of convergence for all three signalling pathways. a) LPS binding to 
Toll-like receptor 4 (TLR4)–CD14–MD-2 complexes activates an intracellular signalling 
cascade that involves the recruitment of MYD88 (myeloid differentiation primary response 
gene 88) and IRAK (interleukin-1-receptor associated kinase). Activation of IRAK results in 
the phosphorylation of TNF-receptor associated factor 6 (TRAF6), which might relay signals 
through the TAK1–TAB1–TAB2 complex to IKK complexes to activate the NF-NB pathway. b)
TNF receptor 1 (TNFR1) engagement by TNF results in receptor trimerization and 
recruitment of the adaptor protein TRADD, which, in turn, interacts with the carboxyl 
terminus of TRAF2, an adaptor protein that has additional affinity for various downstream 
signalling proteins. MAP/ERK kinase kinase 3 (MEKK3) and receptor-interacting 
serine/threonine kinase (RIP) probably link TNF signalling to IKK activation. c) T-cell
stimulation, in response to antigen-presenting cells or anti-TCR-CD3 antibodies results in the 
rapid translocation of protein kinase CT̓ (PKCT) to the plasma membrane. (Li and Verma, 
2002). 
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Class of gene NF-NB dependent gene 
Cytokines/growth factors IL-1D and E
IL-2, -3, -6, -8, -12 
TNF-D, LT-D, IFN-E
G-CSF, M-CSF, GM-CSF 
Immunoreceptors IL-2RD,
TCRD and E, MHC-I, MHC-II 
Adhesion molecules ICAM-1, VCAM-I, 
MAdCAM-I, E-selectin 
Acute phase proteins Angiotensinogen, SAA, 
Complement factors B, C3 and C4 
Others iNOS, Vimentin, 
Cyclin D1, BCL2 
Table 1.3. Selected NF-NB-inducible genes (May and Ghosh, 1998; Siebenlist et al, 1994; 
Chen and Green, 2004). 
1.2 NF-NB-repressing factor (NRF) 
Although NF-NB is kept in its inactive form in the cytoplasm, some level of the NF-NB
proteins is present in the nucleus also in the unstimulated state. Further, many events (Figure 
1.2) stimulate NF-NB activation, but not all NF-NB-regulated genes are induced by each NF-
NB stimulation. Thus, to prevent a constitutive activation of all NF-NB-induced promoters an 
additional regulation of NF-NB activity should take place. NF-NB-repressing factor (NRF) 
was initially identified as a constitutively expressed silencer protein that binds to the negative 
regulatory element (NRE) in the E-interferon (IFN-E) promoter and represses the basal 
transcription of this gene (Nourbakhsh et al, 1993). Later, additional promoters possessing the 
NRF binding site were described. NRE-containing promoters in addition to IFN-E include the 
promoters of IL-8, iNOS genes and HIV and HTLV. The common features exerted by the 
presently investigated NREs are sequence homology, short length (11-13 bp), distance and 
position-independent action and specific silencing of NF-NB-binding sequences (Nourbakhsh 
and Hauser, 1999; Nourbakhsh et al, 2000 and 2001; Feng et al, 2002). A comparison of 
NREs is summarized in Figure 1.4.  
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Figure 1.4 Sequence comparison of the NRE sites in different NF-NB-regulated  promoters. 
NRF specifically binds to a NRE and participates in the transcriptional regulation of NF-NB
target genes. The cDNA of NRF was cloned. Analysis of the NRF expression pattern shows 
that NRF is abundant and ubiquitously expressed. NRF mRNA is detected in all tested cell 
lines and human tissues (Nourbakhsh and Hauser, 1999; Jianfeng et al, 2003).  
The NRF mRNA contains a strong IRES element that results in IRES mediated translation 
(Oumard et al, 2000). EST sequences in public data bases suggest that apart from the NRF 
mRNA examined earlier, other NRF mRNA species might exist that originate from splicing 
of a mRNA from a upstream exon. This mRNA lacks the IRES element but leads to a slight 
extension (18 amino acids) of the N-terminal portion of the NRF protein. Experimentally this 
mRNA and its protein have not been examined yet. Nevertheless, the biological function of 
the IRES element is not understood. The data accumulated to date indicate that it confers high 
translation efficiency which is not perturbed by viral infection and diverse stress responses 
(Oumard et al, 2000 and data not shown).  
Regarding the mechanism of the inhibitory action of the NRF it was shown that NRF at least 
in vitro interacts directly with members of the NF-NB family (Nourbakhsh and Hauser, 1999). 
Thus, NRF acts through both DNA:protein interactions, as well as protein:protein 
interactions.
IL-8-Promoter
hiNOS-Promoter
NRE
-1415 -1405
-6749 -6739
HTLV-I LTR
-134 -124
AATTCCTCCCA
ATTTCCTCTGA
AATTCCTCTGA
HIV-1 LTR
-174 -164
AATTCATCACA
HIV-1 LTR
-394 -385
ACTTCCCTGA
IFN-E-Promoter
-60 -50
AATTCCTCTGA
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In the chromosomal mapping murine NRF gene was positioned to the A4 region of the X-
chromosome (Schwarzer, 2001). The human NRF gene was mapped to human Xq25 
(Schwarzer, 2001; Frattini et al, 1997). 
The NRF gene contains an open reading frame for a protein of 690 amino acids and is 
strongly conserved in human, mouse and rat. Within this protein different structural and 
functional domains were identified (Figure 1.5).  
Figure 1.5. Schematic structure of the NRF protein (according to Niedick et al, 2004).
The DNA (NRE)-binding domain and a domain responsible for constitutive NF-NB repression 
as well as a nuclear localization signal (NLS) were located within the N-terminal part of the 
NRF protein (amino acids 1-388). This is the size of the originally described NRF protein. 
Sequence characterization and blast analysis revealed the existence of a C-terminal part of the 
NRF protein (Niedick et al, 2004). This contains domains including a glycine rich nucleic 
binding domain (G-patch) and a single-stranded nucleic acids-binding domain (R3H). These 
two domains represent potential nucleic-acid binding sites. The G-patch domain exists in a 
number of putative RNA-binding proteins involved in DNA-damage repair and tumor 
supression. Additional dsRNA-binding domains (dsRBD) are found dispersed throughout the 
C-terminal half of the NRF protein (from amino acid 362 to amino acid 550). Although a 
precise definition of the RBD could not be achieved, a binding of the NRF protein to dsRNA 
was clearly confirmed (Niedick et al, 2004).  
The subcellular localization and mobility of the NRF protein was studied (Niedick et al, 
2004). NRF is highly enriched in nucleoli and only little protein is found in the nucleoplasm 
and cytoplasm. It was found that the mobility of NRF located in nucleoli is much lower 
compared to the mobility of nucleoplasmic and cytoplasmic NRF. The dynamic movement of 
a protein in the cell depends not only on its size and shape but also on interactions with other 
factors. Thus, it was suggested that the NRF protein is somehow fixed in the nucleolus. This 
could be due to a direct or indirect binding to nucleolar structures.
NRF is a repressor protein that is thought to be mainly active in the non-induced state of the 
cells. It is possible that NRF is involved in the repression of transcription of nucleolar genes. 
1Repression domain 296
296DBD388
1 690
549G-Patc 596
508JAG663
31NLS46
586R3H663
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This would suggest that the NRF regulated genes are kept in nucleoli in the inactive state but 
are released to the nucleoplasm upon transcriptional activation. This hypothesis was not 
examined yet. 
The promoters in which the inhibitory action of the NRF were best studied are IFN-E
(Nourbakhsh and Hauser, 1999) and iNOS (Feng et al, 2002). The IFN-E promoter was shown 
to be constitutively repressed by a negative regulatory domain (NRD). The NRD was defined 
by the successive deletion of the 5’ regulatory region of the IFN-E gene which led to 
activation of the IFN-E promoter (Goodbourn and Maniatis, 1988). Within the NRD a 
negative regulatory element NRE was identified (Nourbakhsh et al, 1993). Later, the NRF 
protein that binds to the NRE was identified. Deletion or distinct point mutations of the NRE 
as well as inhibition of  the NRF were shown in vitro to affect the constitutive silencing of the 
IFN-E gene expression. 
1.3 NRF target genes
Interferon E (IFN-E)
IFN-E belongs to the family of type I interferons. Interferons (IFN) were discovered as 
antiviral agents during studies on viral interference. The interferon system includes cells that 
synthesize IFN and the cells that respond to IFN by establishing an antiviral state. IFN 
proteins display autocrine as well as paracrine activities. The IFN response represents an early 
host defense and is thus part of the innate immune system. The IFN-E gene is absolutely 
silent, but can be rapidly activated in nearly all differentiated cells. Viruses and dsRNA are 
potent inducers of the IFN-E gene expression. Macrophages produce IFN in response to 
exposure to microbial pathogens or to microbial products like LPS or bacterial DNA (Bogdan 
et al, 2000). Many agents, such as the biological response modifiers IL-1, TNF-D and PDGF, 
are also able to induce the expression of IFN-E, but to a lower extend. IFN-E possesses a wide 
range of biological activities in addition to the characteristic antiviral activity including 
regulation of cell growth, differentiation and apoptosis. IFN-E acts through binding to cell 
surface interferon type I receptors and subsequent activation of the Jak/STAT signalling 
pathway (Samuel et al, 2001). Among the genes induced by the Jak/STAT pathway are those 
of the IRF family. Cooperation of the IRF, STAT and NF-NB transcription factors then results 
in the induction of a network of antiviral genes, including the well characterized dsRNA 
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activated kinase PKR, 2’-5’-oligoadenylate synthase and the Mx proteins that interfere with 
viral transcription and translation processes. 
The highly specific activation of the IFN-E promoter in response to virus infection requires an 
overlapping set of the regulatory elements termed positive regulatory domains (PRDI-
PRDIV). PRDII, PRDI-III and PRDIV are recognized by the transcription factors NF-NB
(p50/p65), IRF-1 and ATF-2/c-Jun respectively (Thanos and Maniatis, 1995). Maximal 
activation of the IFN-E promoter requires cooperative binding of these transcription factors 
together with the high mobility group protein HMGI(Y) which form a multicomponent 
complex, termed the enhanceosome (Figure 1.6).  
LPS induced activation of the IFN-E gene is mediated by TLR4 and leads to the activation of 
NF-NB and IRF-3 (Yamamoto et al, 2004).  
In virus-induced cells, three negative regulatory proteins have been identified modulating the 
activity of PRDs in the IFN-E promoter. IRF-2 and PRDI-BF1/Blimp-1 were described to 
bind to PRDI (Harada et al, 1989; Keller and Maniatis, 1991), while PRDII-BF1 was isolated 
by binding to PRDII (Fan and Maniatis, 1989). The virus-inducible expression kinetics of 
these proteins have established that they are involved in the mechanism of the post-induction 
silencing.
In addition to gene regulatory proteins, chromatin remodeling plays an important role in 
regulation of gene expression. The fundamental structural units of chromatin, the 
nucleosomes, are composed of an octet of histones. The amino-terminus of histone 
polypeptides is subject to different modifications, including phosphorylation, acetylation, 
methylation and ubiquitylation. These modifications affect chromatin structure and contribute 
to the regulation of transcription (Chen and Greene, 2004). It was demonstrated that histone 
acetylation is important regulatory mechanism in the IFN-E and the IL-4 promoters 
(Shestakova et al, 2001; Valapour et al, 2002). In general, acetylated histone tails are found in 
transcriptionally active segments of chromatin, whereas deacetylated histones as well as their 
methylated forms accumulate in transcriptionally repressed regions of chromatin (Imhof and 
Wolffe, 1998). 
The NRE is required for position-independent silencing of the NF-NB site of the IFN-E
promoter. It was shown that in vitro NRF is permanently bound to the NRE and represses 
constitutive activation of the IFN-E promoter. In cell culture experiments the expression of 
the NRF antisense RNA releases the endogenous IFN-E gene transcription (Nourbakhsh and 
Hauser, 1999). 
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Figure 1.6. Transcriptional induction of the IFN-E gene. Virus replication gives rise to 
dsRNA, which is able to activate PKR and perhaps additional cellular kinases. PKR in turn 
activates the IkB kinase and indirectly leads to the activation of the immunomodulatory 
transcription factor NF-kB. Together with ATF-2 and a member(s) of the IRF family, NF-kB 
assembles on the IFN-E promoter with the help of several copies of the accessory factor 
HMG-I/Y to form a multifactorial complex called the‘enhanceasome’. Components of the 
enhanceasome make contacts with factors that are part of the basal transcriptional machinery 
and, by stabilizing interactions with this machinery and causing a local ‘remodelling ’ of the 
chromatin, recruit RNA polymerase II to the promoter to bring about transcription of the 
IFN-E gene. Alternatively, activation of TLR4 by LPS induces a signalling cascade leading to 
activation of IRF-3. Activated IRF-3 forms a homodimer and translocates into the nucleus to 
switch on the induction of IFN-E.
Inducible nitric-oxide synthase (iNOS)
The inducible isoform of nitric-oxide synthase catalyses the production of nitric oxide (NO). 
The NO is generated from the iNOS substrate L-arginin by oxidation of one of the guanidino 
nitrogens. NO is a free radical that acts as a signaling agent and a cytotoxic molecule and has 
microbicidal, antiviral, antiparasital and antitumoral activity (Kleinert et al, 2003).  
LPS
dsRNA
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Like IFN-E, iNOS gene is silent in the unstimulated state, but can be induced by different 
agents. Murine cells express iNOS in response to bacterial lipopolysaccharide (LPS), 
stimulatory cytokines such as IFN-J, IL-1, IL-6, TNF-D and some other. In contrast, the 
majority of human cells require a complex cytokine combination including  IFN-J, IL-1 and 
TNF-D for iNOS induction (Taylor et al, 1998). The induction of iNOS by LPS occurs 
through the activation of a TLR4-dependent signaling cascade, resulting in the activation of 
NF-NB. The sequences of the iNOS promoters in various species including humans and mice 
exhibit homologies to binding sites for numerous transcription factors such as AP-1, GATA, 
IRF-1, NF-1, Oct-1, Stat1 and NF-NB (Kleinert et al, 2003). iNOS activity is regulated 
predominantly at the transcriptional level. It was shown that NF-NB and Stat1 play a key role 
in this regulation (Taylor et al, 1998; Ganster et al, 2001). Upstream to NF-NB binding site a 
NRE-related element was identified in human iNOS promoter (Feng et al, 2002). It was also 
confirmed that in cell culture experiments the NRF protein is involved in constitutive 
silencing of the human iNOS gene by binding to a NRE. 
IL-8
Interleukin-8 (IL-8) is a member of the family of chemokines that acts as mediator of acute 
inflammation. IL-8 synthesis can be induced by pro-inflammatory cytokines such as IL-1 or 
TNF or as a direct consequence of contact with pathogens like bacteria, viruses and stress 
agents. NF-NB plays a key role in the transcriptional regulation of IL-8 gene. By sequence 
comparison with the IFN-E promoter, a NRE was found in the IL-8 promoter. It was also 
shown that NRF binds to the IL-8 promoter NRE. But in contrast to the its role in IFN-E and 
iNOS promoters, in IL-8 transcription NRF was found to have a dual role. In the absence of 
stimulation, NRF is involved in transcriptional silencing, but, in the presence of IL-1, it is 
required for full induction of the IL-8 promoter (Nourbakhsh et al, 2001). 
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2. Results 
Objectives
Transcriptional regulation of most cytokine genes is characterized by strict constitutive 
repression and stimuli-specific activation. The molecular mechanism of this constitutive 
repression is still poorly understood. The recently identified NRF protein (NF-NB repressing 
factor) was proposed to act as inhibitor in some NF-NB regulated promoters. NRF was shown 
to have inhibitory effects on IFN-E (Nourbakhsh and Hauser, 1999), human iNOS (Feng et al, 
2002) and IL-8 (Nourbakhsh et al, 2001) promoters. These studies were carried out on the 
model of in vitro cultured cell lines. With these methods a) characterization of the protein 
function is restricted to a certain cell line and b) cannot enlight interactions of the studied 
protein with other components of the biological system. The developing of gene targeting 
techniques allows the analysis of diverse aspects of gene function in the context of the whole 
organism. Gene targeting involves the inactivation of a given gene in the genome of 
embryonic stem (ES) cells by homologous recombination. ES cells retain their totipotency 
and can participate in the generation of cell lineages of the mouse. Transfer of mutant ES cells 
into mouse embryos thus allows the transmission of the mutation into the mouse germ line 
and generation of animal carrying the mutated gene. Such mutant mice represent a tool to 
investigate the functions of individual genes in the complex biological system. Aim of this 
work was to understand the in vivo function of NRF on the model of NRF-KO mice and 
to study the consequences of NRF deletion in the mutant organism. Because of the 
binding of NRF on various promoters and its inhibitory role it was hypothesized that 1) NRF 
has co-functional (inhibitory and stimulatory) effects on different NF-NB regulated promoters 
2) NRF deficiency can lead to spontaneous expression of certain genes, as for example IFN-E
or iNOS. Such dysregulation of cytokine expression should result in an abnormal phenotype 
of NRF-deficient mice and lead to disturbance of immune defense. In the first part of the work 
presented here the NRF-transgenic mice were created and characterized. The second part 
deals with the effects of NRF protein absence on the molecular level. For this purpose 
different cell types lacking NRF expression were established and analysed. 
2.1 Creation of the NRF-flox mice 
In previous work it was shown (Schwarzer M, 2001), that NRF is expressed already at early 
stages of mouse development. For this reason it was hypothesized that a complete NRF 
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knock-out should lead to lethality during embryogenesis. A variety of strategies have been 
developed to bypass this problem. Of those, the most efficient ones uses the Cre recombinase 
system (Nagy, 2000). The Cre recombinase enzyme of bacteriophage P1 catalyzes 
recombination between two 34 base pair loxP sites (Abremski et al., 1983). If the loxP sites 
are placed in the same orientation on a strand of DNA, the outcome of this enzymatic reaction 
is the excision of the DNA fragment between the loxP sites. Placing the loxP sites itself does 
in most cases not affect gene expression so that the deletion does not appear until Cre-
mediated excision has occured.  
For this purpose a targeting vector was constructed (Schwarzer, 2001). This vector carries the 
endogenous NRF gene, in which part of the second exon is flanked by two loxP sites, with 
insertion of an artificial STOP codon, so that in mice carrying this cassette a short form of 
NRF should be expressed. This short form has been shown to carry the DNA-binding and the 
NF-NB interacting domains (Nourbakhsh and Hauser, 1999). Following expression of Cre-
recombinase the second exon will be excised resulting in a nearly complete deletion of the 
NRF protein (Figure 2.1). In addition, the targeting vector contains the gene for neomycin 
resistance allowing selection of transfected embryonic stem (ES) cells. 
Figure 2.1. Schematic structure of the targeting vector and the genomic modification in 
transgenic mice. In WT mice the NRF protein is expressed (1-690 amino acids), while gene 
targeting is associated with the expression of a “short” version of the protein (1-388 amino 
acids) in floxed animals or lack of the protein in NRF-KO mice (1-38 amino acids). 
The targeting plasmid was electroporated into ES cells and after about 10 days of neomycin 
selection the resistant clones were tested by PCR and Southern Blot analysis. For the PCR the 
polyAATG
neo
lox lox lox
Targeting plasmid: 
In NRF-KO mice: 
ATG
lox
In WT mice: 
ATG
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(“short“ NRF) 
ATG
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lox lox lox
polyA
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primers were designed in such a way that the upstream one (neo) is neomycin gene specific 
and locates inside the exchanged DNA cassette, while the downstream primer (3’-out) 
hybridizes to the endogenous part of NRF gene (Figure 2.2). With these primers one can 
detect clones that have undergone recombination and contain the gene for neomycin 
resistance in their genome. From the tested ES cell clones 3 (5A2, 6A5 and 2B2) were found 
to be recombinant (Figure 2.3). 
Figure 2.2. Schematic presentation the orientation and location ofprimers (arrows) and of 
Southern analysis probes (bars) used in this study. Important restriction enzyme sites are also 
indicated.
To confirm this data and to show specificity of homologous recombination, positive clones 
were tested with Southern Blotting using three different probes: 5’-specific, 2
nd
-exon specific 
and 3’-specific probes (Figure 2.2). Transgene loxP-NRF produces a 6.2 kb EcoRI fragment 
when hybridized with 5’-specific probe, a 4.8 kb SpeI fragment with the 3’-specific probe and 
an 8.7 kb SpeI fragment when hybridized with the 2
nd
-exon-specific probe. An endogenous 
Figure 2.3. Screening of targeted ES
cells clones. Genomic DNA was
isolated from the targeted one-cell
clones of ES cells and tested by PCR
with neo-specific primers. 
In NRF-KO mice: 
In WT mice: 
In floxed mice: neo
2nd exon
EcoRI
EcoRI EcoRI
EcoRI
EcoRI EcoRI
SpeI
SpeI
SpeI SpeI
SpeI
SpeI
SpeI
EcoRI
2nd exon 5‘-end 3‘-end
Southern probes: 
PCR primers: 
3‘-end
3‘-end
2nd exon 5‘-end
5‘-end
SpeI
5‘-itr 3‘-end 3‘-out 
5‘-itr 3‘-end 3‘-out neo
5‘-itr 3‘-end 3‘-out 
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allele should give the following fragments: a 7.5 kb EcoRI fragment when hybridized with the 
5’-end probe; a 13.6 kb SpeI fragment with the 3’-end specific probe and a 13.6 kb SpeI
fragment with the 2
nd
-exon probe. Fragments of different size can be clearly distinguished on 
the Southern blots. All three tested cell clones show the same pattern (Figure 2.4) that 
correlates with the pattern expected in the case of successful homologous recombination. 
Thus these clones were defined as NRF-floxed.
Figure 2.4. Southern blot analysis to confirm homologous recombination in the PCR positive 
clones 5A2, 2B2 and 6A5. Genomic DNA was digested with EcoRI or SpeI and hybridized 
with 5‘-end, 3‘-end or cDNA specific probes as indicated. Pos.cont.=positive control and 
represents digested plasmid DNA with only NRF-flox possible variant of the gene. 
M.C=mixed clones: DNA isolated from the mixed NRF-flox and WT cell populations produce 
therefore both the transgene and the endogenous fragments.
Based on morphological characteristics of the cells, clone 2B2 was chosen for blastocyst 
injection. These NRF-flox ES cells were injected into blastocysts and implanted into 
pseudopregnant recipient mice. As a result, chimeric mice were born. From 5 chimeric mice 
we received 3 males and 2 females with different level of chimerism (40-95%), but only one 
male was able to transmit the NRF transgene into the germ line. This chimeric male was 
crossed with C57BL/6 wild type mice to get a heterozygous NRF-flox female or a 
homozygous NRF-flox male (the NRF gene is linked to the X-chromosome). The genotype of 
all offsprings from this cross was analysed. In the F1 generation mice the NRF transgene can 
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be detected by PCR and Southern Blot analysis. For PCR neomycin resistance gene specific 
primers were used, which revealed the neo-containing flanked form of the NRF gene (data not 
shown). For Southern Blot analysis the NRF 2
nd
-exon specific probe was used (Figure 2.5). In 
the case of heterozygous females two bands were detectable, correlating with the endogenous 
wild type (WT) and the introduced 2B2 or NRF-flox allele. The colony of transgenic mice 
carrying the NRF-flox allele was then established by further breeding of F1 generation mice.  
2.2 Creation of the NRF-KO mice 
In order to get NRF-KO mice NRF-flox mice have to be crossed to Cre-recombinase 
expressing mice. The specificity of gene inactivation depends on the expression pattern of Cre 
recombinase and its regulation. Using time and tissue specific promoters driving Cre 
expression, the flanked gene can be specifically deleted at different stages of the mouse 
development or in the specific tissue or cell types. First, we were interested in effects of a 
complete deletion of the NRF gene and so we used a so called deletor strain of Cre-expressing 
mice. In these mice Cre-recombinase is expressed during early embryogenesis, so that 
excision of the flanked allele occurs before organs and tissues are formed, resulting in a 
complete deletion of the gene. For this work K14-Cre mice were used (Hafner et al, 2004). 
K14-Cre mice express Cre under the control of the keratin 14 promoter. Because of the 
activation of the K14 promoter specifically in the oocyte, when Cre is transmitted by K14-Cre 
females mated to NRF-flanked males, even offsprings that do not inherit Cre, delete the target 
Figure 2.5. Genotyping of F1 generation mice by Southern
bloting. Genomic DNA was digested with SpeI and
hybridized with an NRF cDNA specific probe. The samples
containing both the endogenous WT (13.6 kb) and the
NRF-flox (8.7 kb) allele were defined as heterozygous
(het). WT mice express only the endogenous form of NRF
gene.
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gene. Figure 2.6 shows the expected pattern of genotypes produced from the cross of a 
heterozygous Cre expressing female with a male carrying the NRF flanked allele.  
Figure 2.6. Breeding scheme: crossing between a heterozygous Cre female and a NRF-flox 
male. The excision takes place in all zygotes inheriting the flanked allele, also when the 
offspring does not inherit Cre.
According to the rules of heredity of X-linked genes, females get one of their X chromosomes 
from their father; here it is carrying the NRF flanked allele. In all female zygotes the NRF 
gene will be immediately excised by the Cre recombinase. This occurs independently from 
inheritance of the Cre gene because of the expression of the Cre protein already in the 
outgoing oocyte. Thus, all female offsprings from this cross will be heterozygous for the 
NRF-KO allele. To get homozygous animals series of additional crosses were performed. The 
mice were identified by PCR analysis of DNA isolated from tail biopsy samples. The primer 
pair was designed in the way that different size bands corresponding to WT, NRF flox and 
NRF-KO alleles can be distinguished (location and orientation of primers shown on the 
Figure 2.2). Figure 2.7 shows a representative PCR gel.
Figure 2.7. Genotyping of mice. PCR analysis of 13 mice using 5‘-itr and 3‘-end specific 
primers. The WT allele gives a 2.3 kb fragment, the flanked form of NRF gene –a 3.7 kb band, 
excision of the gene results in a 1.2 kb fragment.
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According to these results mice 1 and 2 contain only the NRF-KO allele, mice 4 and 5 are 
WT, mice 3, 6, 7, 9 and 12 are NRF flox, mice 8, 10, 11 have both WT and flanked alleles 
and are therefore heterozygous, and mouse number 13 is KO heterozygous. To confirm the 
lack of the NRF gene, DNA of KO mice was also analysed by Southern bloting. The DNA 
blot was first hybridized with a NRF 2
nd
 exon specific probe (Figure 2.8, A). In lanes 
corresponding to the KO samples we could not detect any specific band. In contrast, in control 
samples the different size bands are visible, indicating WT or NRF flanked alleles. A second 
hybridization of the same blot with a 5’ specific probe revealed smaller DNA fragment in 
samples from NRF-KO mice, confirming the NRF gene deletion in these samples (Figure 2.8, 
B).
Figure 2.8. Southern blot analysis of DNA from transgenic mice. Genomic DNA isolated from 
tail byopsies was digested with EcoRI and hybridized with the 2
nd
 exon (A) and the 5‘-end (B) 
specific probes as indicated. Hom=homozygous, het=heterozygous mice.
A primary characterization of homozygous NRF-KO mice revealed that the lack of the NRF 
gene is compatible with life and does not cause any visible pathologic effect. 
2.3 Establishment of cells lacking NRF expression
The studies on effects resulting from a lack of the NRF protein on the molecular level were 
carried out with cell cultures in vitro, because these effects can much better be studied in 
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homogenous population of cells. Since NRF can bind to different promoters, which are active 
in different cell types, molecular effects of NRF deletion were studied in specifically 
differentiated cells. For this purpose the following NRF-KO cells were established: ES cells, 
in vitro  differentiated endothelial cells, cell cultures of primary fibroblasts and macrophages. 
In vitro excision of the NRF gene in ES cells 
A method for the creation of mice expressing NRF-floxed allele from the appropriate ES cells 
with subsequent excision of the gene by breeding with a Cre-expressing mice requires a long-
term protocol. For this reason it was decided to use a short-time protocol and establish a line 
of ES cells lacking the NRF gene by using a method of in vitro excision of the NRF gene in 
ES cells. An additional reason for the application of this method was that the NRF gene is 
linked to the X-chromosome and ES cells expressing the NRF-floxed allele are masculine and 
have only one X chromosome per cell. Thus excision of the NRF-floxed allele results directly 
in NRF-KO cells. In addition, functionality of Cre-mediated NRF excision can be tested in
vitro. For this purpose the Cre-recombinase was expressed in NRF-flox ES cells (clone 2B2). 
A plasmid encoding the GFP-Cre fusion protein (Gagneten et al, 1997) was introduced into 
ES cells by electroporation. The cells expressing Cre-recombinase also produced GFP and 
could therefore be selected. We isolated the GFP expressing cells by Flow cytometric cell 
sorting and received about 5% positive cells (Figure 2.9).
Figure 2.9. Sorting of GFP-Cre transfected ES cells. NRF-flox ES cells were electroporated 
with GFP-Cre DNA. 48 hours later GFP positive cells were sorted by Flow cytometry cell 
sorting.
The sorted cells were cultured further and single cell clones were isolated from this culture 
and tested for efficiency of Cre-mediated excision. When excision had occurred and the 
floxed cassette was deleted, one should detect a genomic pattern corresponding to that of the 
NRF-KO situation (see Figure 2.1). The cell clones were analysed by PCR and Southern Blot 
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analysis. Figure 2.10, A shows a representative gel of the PCR products. With the 5’-UTR and 
the 3’-end primer pair both NRF-flox and NRF-KO alleles could be detected (Figure 2.2). The 
NRF-flox allele gives a 3,7 kb band while the PCR product corresponding to the NRF 
deletion has only 1,2 kb. Having this in mind clones 1, 2, 3 and 5 harbor the NRF-KO allele, 
while the clone number 4 was not a pure clone or a clone without deletion. A second PCR was 
performed using neomycin gene specific primers (Figure 2.2). If excision of the NRF-flox 
cassette does not occur, the PCR product should be detectable. As it can be seen in Figure 
2.10, B in DNA from the clones 4 and 5 one can detect the gene for neomycin resistance. The 
clones 1, 2 and 3 are negative for the neomycin gene. This correlates with the deletion of the 
floxed cassette. Clone number 5 harbors both, the NRF-flox and the deleted allele. This can 
be explained by a mixed cell population.  
Figure 2.10. PCR analysis of DNA from GFP-Cre transfected ES clones. A: with NRF-
specific primers; B:  with neo-specific primers. p.c.=positive control for NRF-flox gene. 
To confirm the PCR results and to exclude unspecific integration of the excized DNA 
fragment, the clones were also tested by Southern Blot analysis. The DNA blot was 
hybridized first with a 5’-end specific probe, then stripped and re-hybridised with the NRF 
2
nd
-exon specific probe (Figure 2.11). Hybridisation with the 5’-end specific probe gives a 5.7 
kb fragment in clones 1, 2 and 3, that is smaller as that found in other clones or in the control 
DNA (8.7 kb) and correlates with an NRF gene deletion (Figure 2.11, A). Successful NRF 
gene excision in clones 1, 2 and 3 is confirmed by the second hybridization of the DNA blot 
with NRF 2
nd
-exon specific probe. These clones lack the full NRF gene in their genome (as a 
result of Cre-mediated excision) since no bands could be detected after hybridisation of DNA 
with the NRF 2
nd
-exon specific probe (Figure 2.11, B). The NRF flox allele gives a 8.7 kb 
fragment.  
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Figure 2.11. Southern blot analysis to confirm Cre-mediated excision of NRF gene in ES cell 
clones. Genomic DNA isolated from ES cels clones was digested with SpeI and hybridized 
with a 5‘-end (A) and a 2
nd
 exon specific (B) probe respectevly. 
Putting all this data together we conclude that the NRF-flox cassette was successfully excized 
after expression of Cre-recombinase in the ES cell clones number 1, 2 and 3. These cells were 
therefore defined as NRF-KO. The morphology of NRF-KO ES cells could not be 
distinguished from WT cells by visual inspectation. Further, these cells show no difference 
with respect to the proliferation rate. 
In vitro differentiation of ES cells 
The next step in this study was to create cell lines of differentiated cells expressing mutant 
forms of NRF. ES cells could be differentiated in vitro in number of cell types, as for 
example, muscle, endothelial, neural and some other types. To answer the questions of this 
study it was decided to differentiate NRF-deficient ES cells into endothelial cells. This is of 
advantage since endothelial cells are able to express IFN-E as well as iNOS, the key genes 
shown to be regulated by NRF. The problem of all ES cell differentiation methods is the 
heterogeneity of the cell population. To overcome this we decided to use a recently published 
endothelial cells differentiation protocol (Balconi et al, 2000), that leads to an almost pure 
homogenous population of endothelial cells. The method is based on the use of an endothelial 
cell specific cocktail composed of growth and differentiation factors. This is used during the 
differentiation of ES cells and is followed by a selective immortalization of endothelial cells 
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with Polyoma virus middle T antigen (PymT). PymT was described as immortalization agent 
the exclusively immortalizes endothelial cells (Williams et al, 1988) because of its ability to 
activate cell signalling that is crucial for proliferation of endothelial cells. 
NRF-KO and WT ES cells were differentiated in vitro following a protocol, which is outlined 
in the Figure 2.12. 
Figure 2.12. Schematic representation of procedure to differentiate endothelial cells from ES 
cells. To induce ES differentiation, LIF and feeder cell were removed, and ES cells were 
cultured in the presence of a cocktail of endothelial cell growth factors. Cells formed 
embryoid bodies, which were then collected and disagregated. Endothelial cells were 
developed by direct infection with PymT and selection of puromycin resistant clones.
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ES cells were allowed to differentiate to endothelium by culturing the cells in suspension in 
the presence of the mixture of growth factors. Under this condition, ES cells organize into 
embryonic bodies (EBs). 11 days old EBs were then disaggregated, the cell mixture plated on 
the cell culture dishes and infected with a retrovirus encoding PymT. Endothelial cells 
expressing PymT were selected with puromycin. Non-endothelial cells were lost during the 
cultivation since they lost their proliferation potential. At about the 28
th
 day of cultivation 
puromycin resistant clones of proliferating cells were received, that had a differentiated 
morphology (Figure 2.13). The presence of PymT gene in the genome was confirmed by PCR 
(Figure 2.14).
To show endothelial properties of those in vitro differentiated cells the expression of a typical 
cell surface marker, expressed by endothelial cells was checked: CD34. The cells were 
hybridised with FITC-conjugated anti-CD34 antibodies and measured by FACS (Figure 2.15).  
Figure 2.14. PCR analysis of PymT
expressing virus infected and in vitro
differentiated endothelial cells. PymT-
specific primers were used.
Pos.con.=positive control: DNA of virus
producer cells; neg .con.=negative
control: DNA of non-infected cells.
Figure 2.13. In vitro differentiated
endothelial cells. ES cells were
differentiated following described
protocol. Phase-contrast microscopy of
represantative field is shown (x10).
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.
Figure 2.15. FACS analysis of in vitro differentiated endothelial cells. The cells were stained 
with FITC-conjugated anti-CD34 antibodies and measured (lower pannel). The upper pannel 
shows fluorescence level of the control not-stained cells. 
As it can be seen, about 10% of the cells express the CD34 endothelial marker. The low 
representation of this marker can be explained by a inhomogenous population of cells. This 
could be due to a relative early stage of this cell culture (pasage 4) at which other non-
endothelial cells are still present, indicating that the cell population is not homogenous. It is 
assumed that those are eliminated during further culture. We conclude that by this in vitro
differentiation and immortalization of ES cells endothelial cells were obtained and can be 
used for specific expression analysis. 
Cell cultures of primary cells
Primary fibroblasts were isolated from the skin of newborn 2-3 days old mice. These cells 
have a high proliferation potential, can be propagated in culture beyond passage 8, are easy to 
keep, give rise to homogenous cultures and represent therefore an excellent model for in vitro
studies. The primary skin fibroblasts isolated from WT and NRF-KO mice were 
morphologically indistinguishable and had similar proliferation rates. 
Resident peritoneal macrophages were freshly isolated for each experiment from the 
peritoneal space of WT and NRF-KO mice. These cells play a major role during immune 
response and inflammation process. Macrophages represent, therefore, ex-vivo model system 
for the study of immunological processes.   
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2.4 Molecular characterisation  of NRF-KO cells
RNA analysis
Analysis of DNA from tail biopsies showed that KO mice contain a truncated form of the 
NRF gene in their genome. Transcription from the NRF-KO allele can still be initiated 
because of the presence of the 5’ region and the 1
st
 exon. But since the 2
nd
 exon is deleted 
together with part of the intron, which contains the splice acceptor, the NRF-KO RNA cannot 
be processed by splicing. Thus, the KO mRNA contains one intron sequence that is normally 
removed by splicing. Multiple STOP codons present in the intron region prevent translation of 
NRF-KO mRNA to a protein of more that 38 amino acids. Transcription from the NRF-KO 
allele should result in mRNA with the same size as the WT form: 3,9 kb. The NRF flanked 
mRNA contains in addition the gene for neomycin resistance and is therefore larger in size: 
5,2 kb (Figure 2.16). It was not clear wether the artificial NRF-KO RNA is stable enough to 
be detected. Thus NRF gene expression in primary murine fibroblasts was tested by RNA and 
protein analysis. 
Figure 2.16. Schematic structure of WT, NRF-floxed and NRF-KO forms of mRNA.
RNA was isolateded from cultured cells and analysed by Northern blot analysis. Figure 2.17 
shows a representative mRNA blot hybridised with 2
nd
 exon specific DNA fragment. As 
expected, in KO cells no NRF specific mRNA was obtained because of lack of the major part 
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splicing
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polyA
ATG
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of the NRF gene. In heterozygous cells containing both WT and NRF flanked alleles two 
different mRNA were detected, representing the WT and the NRF flox form.  
Protein analysis
The NRF protein in WT cells was shown to localize predominantly in nucleoli (Niedick et al, 
2004). Therefore, for protein analysis nuclear extracts were isolated from WT and NRF-KO 
cells and tested by Western Blot analysis using specific antibodies directed against NRF 
(Figure 2.18, A). The calculated molecular weight of the NRF protein is 77,6 kD. In nuclear 
lysates isolated from WT cells a specific band just above this size can be detected. The 
antibody is directed against amino acids 671-690 at the C-terminus of the NRF protein. The 
coding region of this part is not eliminated in NRF-KO cells and should also be encoded by 
the mRNA (Figure 2.16). However, it should not become translated into protein because of 
multiple upstream STOP codons in the intron sequence. Indeed, in lysates isolated from KO 
cells no protein band was detected confirming the lack of any form of the NRF protein in 
these cells. To confirm specificity of the antibody the gel was loaded with cell extracts 
isolated from C243 cells stably overexpressing a myc-tagged-NRF protein. Myc-tagged NRF 
could be detected by re-incubation of the protein blot with anti-myc antibodies (Figure 2.18, 
B). The difference in the molecular weight of endogenous NRF and myc-NRF is explained by 
the myc epitope. 
Figure 2.17. Northern blot analysis.
mRNA was isolated from WT, NRF-KO
and NRF-flox cells. The RNA blot was
hybridized with  a radioactively labelled
NRF 2
nd
exon specific probe. For each
sample 2mg mRNA was loaded.
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Figure 2.18. Western blot analysis of NRF expression. Nuclear extracts were prepared from 
WT and NRF-KO primary cells as well as from a C243 cell line, overexpressing the myc-
tagged NRF protein and empty cells. For primary cells 30 mg and for C243 cells 15 mg 
protein was loaded per lane. The protein blot was incubated with anti-NRF antibodies (A) 
and in a second round with anti-myc-tag ABs (B). 
Indirect immunofluorescence was used to show the level of protein expression and its 
localization in fixed cells. WT and NRF-KO cells were fixed on the glass slides and stained 
with the antibodies directed against the NRF protein (Figure 2.19). In a previous study 
(Niedick et al, 2004) it was shown that the overexpressed myc-tagged NRF protein is 
predominantly localized in the nucleolus. The experiment shown in Figure 2.19 demonstrates 
that the localization of the endogenous NRF protein is also restricted to the nucleolus. In KO 
cells any specific staining with anti-NRF antibodies was detected, confirming the complete 
deletion of the NRF protein in these cells. Myc-tag NRF expressing cells were used as a 
positive control in this experiment (data not shown). 
Figure 2.19. Immunofluorescence. The WT or NRF-KO cells were fixed and then incubated 
with ABs directed against NRF. The secondary AB was fluorescence labelled. Vizualization 
was performed  by confocal laser scanning microscopy. 
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In in vitro studies it was shown that the NRF protein specifically binds an NRE sequence in  
NF-NB regulated promoters. NRE-related sequences have been identified in several 
promoters, including IFN-E, iNOS, HIV-1 and IL-8. But binding of NRF to the NRE in the 
IFN-E promoter was best characterized. Human and murine IFN-E promoters are highly 
homologous. Because of this reason the NRE sequence from the murine (identical to the 
human) IFN-E promoter was used to study the DNA-binding property of endogenous NRF 
protein in murine cells. Nuclear extracts isolated from WT, NRF-flox and NRF-KO cells were 
incubated with the radioactively labelled NRE fragment (Figure 2.20, A). The electromobility 
shift assay (EMSA) revealed, however, that NRF is not the only factor that binds to the NRE. 
Protein binding to the NRE was obtained also with lysates from KO cells. Using the 
unlabelled NF-NB specific sequence as a cold competitor it is shown that NF-NB is the protein 
that binds to the NRE in vitro. Different approaches were undertaken to show specific NRF 
binding. Unfortunately it could not be clarified whether both proteins bind DNA 
simultaneously or if they compete for the binding. 
Figure 2.20. Electromobility shift assay. Nuclear extracts isolated from primary WT, NRF-
flox and NRF-KO cells were incubated with radiolabeled IFN-E promoter NRE 
oligonucleotide (A). Competitions with unlabelled (Cold comp.) NF-NB consensus sequence is 
also indicated (B). 
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Gene expression profile of the NRF-KO cells
The recently released AFFYMETRIX GENECHIP Microarray Technology allows 
simultaneous and quantitative analysis of the mRNA expression profile for 22629 probe sets, 
corresponding to more than 15000 genes within a single experiment. For application of this 
method total cell RNA is fluorescence labelled and used for hybridization on the chip. 
Binding of labelled mRNA to the appropriate DNA fragment results in a specific fluorescent 
signal that can be instrumentally quantified. Comparison of the intensity of fluorescent signals 
from the sample to a control allows the identification and the quantification of differentially 
regulated genes. The microarray experiment involved the following steps: preparation of 
fluorescently labelled probes from RNA isolated from WT and KO primary cultured 
fibroblasts that was labelled and hybridized to the microchips. Afterwards, the chips were 
scanned and the received images were analysed. From these results the gene expression 
profiles were deduced. Figure 2.21 shows the expression pattern of KO cells compared to that 
of WT cells. 25 genes were found to be down- and 17 - up- regulated in NRF-KO cells. 
However, the degree of this diference is rather low and cannot be regarded as statistically 
significant. It was therefore concluded that there is no difference between the gene expression 
pattern in primary cultured WT and NRF-KO fibroblasts. A difference in the expression level 
of sex chromosome specific genes (inactive X specific transcript, eukaryotic translation 
initiation factor 2 and DEAD box polypeptide) serves as internal control of the method. WT 
cells were isolated from the female mice whereas NRF-KO cells are derived from the male 
animals. 
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Figure 2.21. Comparison of gene expression profile of NRF-KO relative to that of the WT in 
primary cultered fibroblasts. Negative values represent genes, which expression was down-
regulated and positive values those with up-regulation in NRF-KO samples.
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Effects of NRF deletion on IFN-E gene expression
NRF was identified as inhibitory factor, binding to the IFN-E promoter and preventing its 
production in the unstimulated state. Therefore, lack of the NRF protein could lead to some 
constitutive level of IFN-E production. ES cell were characterised as cells that are not able to 
produce interferons (Francis et al, 1989). NRF-KO ES cells retain this property. In the 
supernatants of WT and NRF-KO ES cells stimulated with virus and of those remained 
unstimulated IFN-E was not detected (data not shown). This effect is explained by a general 
unability of ES cells to produce IFNs, which is due to an inhibiting mechanism on the 
epigenetic level in ES cells. However, IFN-E can be produced by nearly all differentiated cell 
types. Thus, WT and NRF-KO primary fibroblasts were subjected to an IFN antiviral assay. 
In this assay cells are infected with virus (Newcastle Disease Virus, NDV) for the induction 
of IFN expression. Then the cells produce IFN for 24 hours and finally supernatants from 
induced and control uninduced cells are tested for their ability to protect IFN-responsive 
LMTK
-
 cells from infection with Vesicular Stomatitis Virus (VSV). LMTK
-
 cells that do not 
undergo lysis upon infection with VSV are therefore incubated with supernatants containing 
sufficient IFN to protect the cells. Comparison of the ability to protect LMTK
-
 cells with IFN 
from the supernatants with that of a standard IFN-E sample, the concentration of IFN 
produced by the test cells can be determined. In Figure 2.22 crystal violet staining of the 
LMTK
-
 cells 24h after infection with VSV is shown. As it can be seen, cells that were 
incubated with supernatants from control, non-induced WT, NRF flox and KO cells did not 
survive the VSV infection. This indicates that NRF-KO cells do not constitutively produce 
IFN-E or the level of this production is undetectable with this method. On the other hand the 
IFN-E production by the cells stimulated with NDV is similar in WT and NRF-KO cells. 
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Regulation of IFN-E is strictly controlled and even low levels of a basal expression might 
have physiological effects. A more sensitive method than the antiviral test is an analysis of 
gene expression with RT-PCR. Total RNA isolated from WT and NRF-KO cells was reverse-
transcribed and then tested by PCR using IFN-E specific primers (Figure 2.23). With this 
method no IFN-E production by NRF-KO cells was found. We also tested with this method 
the endothelial cells we obtained by in vitro differentiation of ES cells (see chapter 2.3), but 
with the same result. As a positive control RNA isolated from mouse embryonic fibroblasts 
(MEFs) was used. These cells are known for their ability to produce low level of IFN-E in the 
unstimulated state (Zawatzky, not published).  
Effects of NRF deletion on iNOS activity
Another gene, whose expression is regulated by NF-NB and that was shown to have an NRF 
binding site in its promoter is inducible Nitric Oxide Synthase (iNOS) (Feng et al, 2002). The 
iNOS gene is transcriptionally silent in the unstimulated state, but can been rapidly induced 
Figure 2.22. Test for IFN production.
LMTK cells were incubated for 24h
with supernatants from WT, NRF flox
and NRF-KO cells that were pre-
induced with NDV or left untreated
(as indicated). LMTK
-
 cells were
subjected VSV infection and 24h later
stained with crystal violet. Cells in
the first line were incubated with
standard murine IFN-E.
Figure 2.23. RT-PCR. RNA was
isolated from cultured WT, NRF flox,
NRF-KO and MEFs. mRNA was
reverse-transcribed into cDNA and
subjected to PCR analysis using
IFN-E specific primers. Pos.
con.=positive control that represents
genomic DNA. 
IFN-E
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by different agents, for example, by LPS. As a result of iNOS activity Nitric Oxide (NO) is 
produced. This molecule plays an important role in antibacterial and antiviral immunity. 
Because of the proposed modulatory role of NRF for transcriptional repression of iNOS gene 
it was hypothesized that a lack of the NRF inhibitory action in the iNOS promoter could cause 
some expression level of this enzyme in unstimulated conditions and lead to accumulation of 
NO. The cells known for their ability to express high level of iNOS are endothelial cells and 
macrophages. Native peritoneal macrophages from WT and NRF-KO mice were isolated and 
analysed for possible constitutive iNOS activity. The sensitive RT-PCR analysis was 
performed using iNOS specific primers. However, no basal expression of the mRNA could be 
detected (data not shown). To check the induction of iNOS activity in freshly isolated NRF-
KO primary macrophages these cells were induced with 10 Pg/ml of LPS and analysed for 
NO production. NO is an unstable molecule with a very short half-life time and can therefore 
not be detected directly. By oxygen and water NO is rapidly converted into the more stable 
NO2 molecule. The NO metabolite NO2 accumulates in the extracellular space and can be 
quantitatively measured. Its concentration correlates with level of NO production by the test 
cells. Figure 2.24 shows the rate of measured NO2 in WT and NRF-KO cells 24 and 72 hours 
after induction with LPS.
Figure 2.24. NO2 production by macrophages.  Freshly isolated WT (grey bars) and NRF-
KO (black bars) macrophages were stimulated with 10mg/ml LPS. NO2 was measured in the 
supernatants 24 and 72 hours after stimulation with Griess reagent.
This experiment indicates that iNOS expression can be induced in cultured primary 
macrophages. NO production can be measured already 24h after stimulation, but is 
2. Results  34   
significantly increased 72 h after stimulation and the induction level is similar in WT and 
NRF-KO cells. 
In experiments described above a possible effect of the lack of the NRF protein was tested 
with the model of in vitro cultured NRF-KO cells. In contrast to the expectation, we couldn’t 
detect any basal expression of IFN-E or iNOS genes in unstimulated NRF-KO cells. NRF-KO 
cells were isolated from the normally developed newborn (fibroblasts) or adult (macrophages) 
mice. Both, IFN-E and iNOS, are strictly regulated genes with a number of factors involved in 
their control. We hypothesize, that during embryogenesis mechanisms might be activated to 
compensate the lack of the NRF protein. Such mechanisms could involve over-activity of 
other factors participating in the constitutive silencing of NF-NB regulated promoters. So that 
compensatory mechanisms override the immediate phenotype of the eliminated NRF gene. 
This can be tested in vitro. To do so, we decided to delete the NRF gene in cultured cells 
using the Cre-loxP system. For this purpose in primary cells which are homozygous for the 
NRF floxed allele the Cre recombinase must be expressed. For this a method that allows 
efficient and rapid excision of a functional floxed locus was needed. Because primary cells 
are usually difficult to transduce our method of choice was retroviral infection and subsequent 
selection for the successfully treated cells. 
2.5 In vitro excision of NRF gene in primary cells by retroviral Cre transduction 
Retroviruses
Retroviral infection is a DNA transfer technique that allows efficient introduction of nucleic 
acids in diverse cell types, even where the general transfer methods like transfection and 
electroporation fail.
A specific feature that characterizes all retroviruses is that a single particle contains two 
copies of the single stranded genomic RNA, which after infection of the target cell is reverse 
transcribed to the complementary double stranded proviral DNA that integrates into the host 
genome. Proviral DNA terminates at the both 5’ and 3’ends by two identical long terminal 
repeats (LTRs). This region contains the control promoter/enhancer elements for viral gene 
expression. The viral genome contains genes that essential for viral replication, usually there 
are 3 genes, encoding for precursor of capsid protein (gag and env) and protease responsible 
for the cleavage of gag polyproteins (pro). Retroviral vectors are constructed in a way that the 
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structural viral genes are replaced by the gene of interest. Upon integration into the genome of 
infected cells introduced nucleic acids are transcribed, but new viruses will not be assembled 
because of the lack of essential proteins. For the production of the retroviruses packaging cells 
were developed, which provide the retroviral proteins by expression in trans.
Construction of the retroviral vector
A retroviral vector for the constitutive expression of a GFP-Cre fusion protein was 
constructed (Figure 2.25). The fusion of the Cre recombinase to GFP allows analysis of 
infected cells by FACS and sorting effectively transfected cells. Expression of the GFP-Cre 
fusion protein is driven by the retroviral internal LTR promoter. The GFP-Cre gene is 
followed by the gene encoding the neomycin resistance under the translational control of 
IRES (internal ribosomal entry site), that allows additional selection. 
Figure 2.25. Schematic presentation of retroviral construct encoding for GFP-Cre fusion 
protein.
Establishment of the producer cell line
The packaging cell line GP+E86 was transfected with the GFP-Cre retroviral vector. To get 
stable virus producers the transfected cells were selected for neomycin resistance. A titer of 
pM5GFPCreneo transfected packaging cells was determined on mouse fibroblasts NIH3T3 
cells. The titer was 2,8x10
5
 cfu/10
6
 cells in 24 hours.
Expression analysis
The efficiency of infection with pM5GFPCreneo was tested on the mouse fibroblast cell line 
NIH3T3, to find optimal conditions for infection. Infection with different MOI (multiplicity 
of infection) was tested. The MOI indicates virus/cell ratio. The best infection efficiency was 
reached when 2x10
4
cells were infected with 10
5
viruses (MOI = 5). 
The kinetics of infection with pM5GFPCreneo was also tested. GFP expression was measured 
in the infected cells 24, 48 and 72 hours after infection. The level of GFP expression was 
analysed by FACS (Figure 2.26).
LTR LTRGFP Cre IRES Neo
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Figure 2.26. Kinetics of GFP expression after infection. NIH3T3 cells were infected with 
supernatant containing  pM5GFPCreneo virus with MOI=5. 24, 48 and 72 hours after 
infection GFP expression by the cells was measured by FACS.
At 24 hours after infection expression of GFP-Cre protein was not detectable. 48h after 
infection a significant level of GFP-Cre expression (35%) was reached. This level was 
increased 72h after infection (50%). 
Infection of primary cells
The freshly isolated mouse skin fibroblasts (see chapter 2.3) from WT and NRF-flox mice 
were infected with pM5GFPCreneo retrovirus at the same conditions that were established for 
NIH3T3 cells. 24, 48 and 72 hours after infection the cells were tested for GFP expression 
(Figure 2.27, A).
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Figure 2.27. GFP-Cre expression in primary fibroblasts. Cells isolated from the skin of 
newborn mice were infected with supernatant containing  pM5GFPCreneo virus. In indicated 
time after infection (24, 48 and 72 hours) infected cells were measured by FACS for GFP 
expression (A). B. Overlaying histograms of control (grey area) and infected cells 48h after 
infection (green line) and 72h after infection (pink line).
The level of the GFP expression was significantly lower as that shown for NIH3T3 cells: 
about 4% 48h after infection and 7% 72h after infection. However, the overlaying histogram 
(Figure 2.27, B) shows that most of infected cells are slightly shifted towards GFP positive 
cells. This indicates that most cells exhibit some, but a relatively low level of GFP expression. 
Thus, the low percentage of GFP positive cells is caused by technical difficulties to detect 
GFP expression in primary cells. Another reason is that the used GFP fused to Cre is the WT-
GFP and not an enhanced form of the protein (eGFP).  
Based on the data from FACS analysis (Figure 2.27) one could imagine that upon infection 
with pM5GFPCreneo retroviruse even cells that are not detected as GFP positive express 
some GFP-Cre fusion protein. This could subsequently lead to Cre mediated excision of the 
NRF gene. To check the ability of GFP-Cre fusion protein to delete the flanked gene infected 
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cells were analysed with PCR. DNA was isolated from NRF flox cells 72 hours after infection 
and analysed with NRF flox and KO specific primers (Figure 2.28).  
An 1,2 kb band is specific for the NRF deletion. The presence of this band indicates that Cre 
recombinase fused to GFP protein is functionally active and mediates excision of the flanked 
cassette. However, there is still a population of cells with insufficient level of Cre expression 
and these cells retained the NRF flox genotype (indicated by the 2,0 kb band).
Thus, retroviral infection of primary fibroblasts with GFP-Cre viruses results in a mixed 
population of uninfected or insufficiently infected NRF flox cells and those that have 
successfully undergone Cre mediated excision. In order to get a homogenous population of 
cells to study the NRF gene deletion it is essential  to separate NRF-KO from the rest of the 
cells. The fusion of the Cre recombinase to GFP allows the sorting of the infected cells by 
Flow cytometry and to obtain a homogenous populations of Cre expressing cells. An 
experiment was performed in which WT and NRF flox cells were infected with 
pM5GFPCreneo virus followed by sorting for GFP expression 72 hours after infection. A 
respresentative experiment is shown in Figure 2.29. 12% GFP positive WT cells and 25% 
GFP positive NRF flox cells were obtained. In all experiments the value of GFP positive cells 
fluctuates between 10 and 30% and does not depend on the cell type (WT or NRF flox). The 
sorted cells were cultured  further 6 days and RNA was isolated.
Figure 2.28. PCR analysis of
GFP-Cre virus infected NRF
flox cells. DNA was isolated
from NRF flox cells 48 and 72
hours after infection and tested
with NRF flox and KO specific
primers.
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Figure 2.29. Sorting of GFP-Cre infected cells. WT and NRF-flox primary fibroblasts were 
infected with GFP-Cre virus. 72 hours later GFP positive cells were isolated by  cell sorting.
The deletion of the NRF gene was tested by RT-PCR. For detection of NRF-KO cDNA with 
PCR one of the primers was intron specific, the other was located on the 3’-end (Figure 2.30). 
In parallel PCR for detection of WT and NRF flox alleles was performed.  
As expected, in WT cells GFP-Cre infection does not affect NRF mRNA expression and only 
the WT mRNA is found. In the sorted NRF flox cells no sign of RNA from the floxed allele is 
detected, but only the product corresponding to the NRF excision. Thus sorting of GFP 
Figure 2.30. Characterization of cells
with the in vitro deleted NRF gene by
RT-PCR. RNA was isolated from sorted
GFP positive cells (WT and NRF flox),
produced by infection with GFP-Cre
virus. mRNA was reverse-transcribed
into cDNA and subjected to PCR
analysis using NRF-WT and NRF-KO
specific primers. 
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positive cells upon infection with GFP-Cre retroviruses results in a pure population of cells 
that express the GFP-Cre at levels sufficient for complete Cre-mediated excision of the 
flanked allele.
The homogenous population of NRF-KO cells is produced from cells that carried the NRF 
flanked allele (by retroviral Cre transduction) in cultured primary cells within a few days. To 
investigate whether this sudden excision of the NRF gene causes immediate activation of NF-
NB regulated promoters the expression level of IFN-E in these cells was analysed. RNA 
isolated from WT and NRF-KO cells that were sorted upon infection with GFP-Cre 
expressing retroviruses was examined by RT-PCR using IFN-E specific primers (Figure 2.31). 
Neither WT nor the freshly deleted NRF-KO cells express IFN-E in the non-stimulated state. 
As a positive control for RT-PCR the expression of the housekeeping gene GAPDH was 
confirmed (Figure 2.31). 
This result let us conclude that even in freshly deleted NRF-KO cells the lack of NRF protein 
alone is not sufficient for activation of promoters, in which NRF is supposed to have an 
inhibitory role. Thus, the sudden deletion and deletion in the early embryonal development do 
not differ in this respect.  
2.6 Overexpression of NRF in primary cells 
To study effects of excessive expression of the NRF the protein was overexpressed in primary 
cells. For this purpose a retroviral vector for the constitutive expression of NRF was 
constructed (Figure 2.33).
Figure 2.31. IFN-E expression assay of
freshly deleted NRF gene in primary
cells by RT-PCR. RNA was isolated from
sorted GFP positive cells (WT and NRF-
KO), produced by infection with GFP-
Cre virus. mRNA was reverstranscribed
into cDNA and subjected to PCR
analysis using IFN-E and GAPDH
specific primers. Pos. con.=positive
control and represents genomic DNA.
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Figure 2.33. Schematic presentation of retroviral construct encoding for myc-tagged NRF 
protein.
For detection of the NRF protein a myc-tag was coupled to the N-terminus of the NRF 
protein. The myc-epitope represents six repeats of 13 amino acids, each representing a 
recognition site for the available antibody. This epitope is derived from the c-myc protein and 
can be specifically detected with anti-myc-tag antibodies. Expression of the mRNA is driven 
by the retroviral  LTR promoter. The NRF reading frame is followed by the reading frame 
encoding a fusion protein that is composed of GFP, thymidine kinase and gene for neomycin 
resistance (GTN). Its translation is under the control of an IRES (internal ribosomal entry site) 
element. This fusion protein allows multiple selection procedures.  
The virus producing cell line was established by stable transfection of the packaging cell line 
GP+E86 with pM5mycNRFgtn retroviral vector. 
The efficiency of pM5mycNRFgtn infection was tested on primary cultures of mouse 
fibroblasts. The cells were infected with pM5mycNRFgtn virus and 48 hours later GFP 
expression was analysed by FACS (Figure 2.34). Nearly 50% of all infected cells were 
defined as GFP positive, indicating a high rate of infection. 
Figure 2.34. Primary fibroblasts isolated from the skin of newborn mice were infected with 
supernatant containing  pM5mycNRFgtn  virus. 48 hours after infection cells were measured 
by FACS for GFP expression.
To check the localization pattern of overexpressed NRF introduced by retroviral infection, the 
pM5mycNRFgtn-infected cells were stained with anti-myc-tag antibodies and analysed by 
immunofluorescence (Figure 2.35). The localization pattern of retroviraly overexpressed NRF 
is completely identical with that of endogenous protein which is concentrated in the nucleoli.  
LTR LTRNRF IRES GTNMyc-tag 
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Figure 2.35. Immunofluorescence. The primary WT fibroblasts were infected with 
supernatant containing  pM5mycNRFgtn  virus. 48 hours after infection cells were fixed and 
GFP expression was analysed by confocal laser scanning microscopy. In both, high 
expressors and in the cells that express the NRF protein in lower level, the same expression 
pattern was obtained. 
Thus, the endogenous NRF protein as well the overexpressed one by different gene transfer 
methods in various cell lines localizes to the nucleolus. 
2.7. Effects of NRF deficiency and overexpression on the gene expression pattern
In order to determine the genes whose expression is directly affected by NRF, we applied 
RNA to Microarray Analysis. Microarray technology allows large scale profiling of gene 
expression. For this analysis primary mouse fibroblasts isolated from WT, NRF-flox and 
NRF-KO mice were used as it is outlined on the Figure 2.36. 
Figure 2.36. Schematic presentation of the samples used for analysis with Microarray 
technology.
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1
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 To test effects of sudden NRF deletion NRF-flox cells were infected with the GFP-Cre 
expressing retroviruses with subsequent sorting of GFP positive cells (sample 2). For a 
control WT cells were used that were subjected to the same experimental procedure (sample 
1). To compare effects of NRF gene rapid deletion with a constitutive deficiency NRF-KO 
cell were infected with the same virus, but not sorted (sample 3). In addition, WT and NRF-
KO cells were infected with myc-NRF expressing virus to monitor direct effects of NRF 
overexpression (samples 4 and 5). Total cell RNA was isolated from the test cells and applied 
to AFFYMETRIX GENECHIP Microarray Analysis. Image files were analysed using 
Affimetrix software that included three steps: background adjustment, normalisation and 
summarisation. Thereafter the data was analysed bioinformatically. Cluster analysis was 
performed using programme “Genesis”. Cluster analysis groups together genes with 
comparable patterns of expression by employing mathematical methods of similarity organise 
patterns of expression. Such analysis of NRF deficient or overexpressed samples gives 10 
clusters with differently regulated gene expression pattern (Figure 2.37).
Figure 2.37. Cluster analysis of genes affected by  changes in the NRF expression.
Clusters A, B and J group genes that are downregulated by sudden inactivation of NRF 
(sample 2), but remain unaffected in NRF overexpressing cells (samples 4, 5) as well as in 
1 32 54 1 32 54 1 32 541 32 54
1 – WT 
3 – embryonal KO
2 – sudden KO
5 – mycNRF on KO 
4 –mycNRF on WT
1 32 54 1 32 54 1 32 541 32 54
1 32 54 1 32 54
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NRF-KO cells (sample 3). Figure 2.38 highlights the genes within this cluster. In contrast, 
cluster H contains the genes, which expression is up-regulated by sudden deletion of the NRF. 
Genes regulated by overexpression of the NRF protein are summarized in cluster C (up-
regulation) and cluster E (repression), comparing WT cells infected with myc-NRF virus 
(sample 4) with WT GFP-Cre expressing cells (sample 1). Genes of these expression pattern 
are shown on Figures 2.39.
To classify clustered genes affected by changes in NRF expression to functional network 
additional analysis of gene ontology was performed using GeneMap and Go Surfer software. 
Figure 2.40 shows one example of the affected genes in apoptosis regulation signaling, 
comparing “sudden” NRF-KO cells with WT cells. Deletion of NRF leads to inhibition of 
expression of some proapoptotic genes (CytC, caspase3) as well as NF-NB activating kinase 
IKK. This correlates with upregulation of Mdm2 that acts as a ubiquitin ligase and targets p53 
for destruction by proteasomes and promotes p53 degradation (Figure 2.40, A). On the other 
hand overexpression of the NRF directly up-regulates one of the key proapoptotic genes p53 
(Figure 2.40, B). Regarding the influence of NRF deficiency on genes of the immune system 
we found both up- and downregulation effects. The most interesting data is summarized in 
tables 2.41 and 2.42.
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Figure 2.38. Genes
that were organized
in cluster A. 
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Figure 2.39. Genes that were
organized in clusters C and E. 
Cluster C Cluster E 
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Figure 2.40. Factors of the apoptosis signaling pathway affected by NRF deletion (A) and 
NRF overexpression (B). Red marked are genes which expression is up-regulated; green 
marking represents the down-regulated genes. 
A
B
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Table 2.41. Genes of the immune response system undergone up- or down-regulation upon 
rapid deletion of the NRF. 
Gene symbol Affy regulation Unigene title 
Fcgrt 2,2 Fc receptor, IgG, alpha chain transporter 
Ccl8 3,2 Chemokine (C-C motif) ligand 8 
Il20 15,4 Interleukin 20 
Mail-pending 2,1 Molecule possessing ankyrin-repeats 
Saa3 5,3 Serum amyloid A3 
Gadd45g 2,3 Growth arrest and DNA-damage inducible 45 
Ada -2,3 Adenosine deaminase 
Ifi202b -3,3 Interferon activated gene 202B 
Swap70 -1,8 SWAP complex protein, 70 kDa 
Bcap31 -2,6 B-cell receptor-associated protein 31 
Table 2.42. Genes of the immune response system undergone up- or down-regulation upon 
NRF overexpression. 
Gene symbol Affy regulation Unigene title 
Cxcl5 2,1 Chemokine (C-X-C motif) ligand 5 
Illr11 1,8 Interleukin 1 receptor-like 1 
Cd44 1,6 CD44 antigen 
Bcl10 2 B-cell leukemia/lymphoma 10 
Gadd45g 1,7 Growth arrest and DNA-damage-inducible 45 gamma 
Ly6a -1,6 Lymphocyte antigen 6 complex, locus A 
B2m -1,7 Beta-2 microglobulin 
Ccl8 -1,9 Chemokine (C-C motif) ligand 8 
Pla2g7 -2,3 Phospholipase A2, group VII (platelet-activating factor)
Bmi1 -2,6 B lymphoma Mo-MLV insertion region 1 
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3. Discussion 
3.1 Creation and characterization of NRF-KO mice 
mRNA of NF-NB repressing factor NRF was shown to be abundant and ubiquitously 
expressed in all tested cell lines and adult tissues (Nourbakhsh and Hauser, 1999; Frattini et 
al, 1997; Jianfeng et al, 2003). Based on the cell culture studies the function of NRF protein 
was defined as a constitutive inhibitor of NF-NB regulated promoters. To investigate the 
physiological function of NRF in vivo mice lacking NRF protein were created. This work 
describes the generation of these mice. By homologous recombination in mouse ES cells the 
encoding region of the endogenous NRF gene was replaced with a piece of recombinant 
DNA. The resulting locus still contains the NRF gene but half of the protein encoding the C-
terminal fraction is flanked by loxP sites and the gene encoding neomycin resistance 
introduced into the 2
nd
 exon of the NRF gene (Figure 2.1). By this gene interruption the 
expression of a truncated form of the NRF protein was achieved. This form contains a nuclear 
localization signal (NLS), the DNA binding domain (DBD) as well as the NF-NB repressing 
domain, whereas the nucleic acid binding domains G-Patch and R3H and consensus sequence 
motifs for RNA binding (JAG) are eliminated. Following blastocyst injection and breeding of 
chimeric mice, a colony of mice that carry the flanked NRF allele and express the “short” 
NRF was established. Expression of the flanked form of the NRF was confirmed by analysis 
of cellular mRNA with Northern Blots (Figure 2.15). Unfortunately, the existence of this 
short form of the NRF protein could not be proven because of the non-availability of a 
specific antibody. The expression level of mRNA corresponding to the flanked NRF is similar 
to that of the WT form. This let us expect normal translation and production of the truncated 
form of the NRF protein. 
Mice with a complete deletion of the NRF gene (NRF-KO) were produced by crossing the 
NRF-flox animals with those expressing Cre recombinase. Upon recombinase action the 
flanked cassette including the major part of the NRF gene is excised, giving rise to mice 
completely lacking expression of the NRF protein. NRF absence was tested on different 
molecular levels: on the DNA level - with PCR, Southern Blot Analysis and sequencing; on 
the level of RNA – with RT-PCR and Northern Blotting; and on the protein level - by 
Western Blot analysis and Immunofluorescence. Since NRF-KO cells still contain the 5’ UTR 
of the NRF gene, 1
st
 exon and the distal part of the 2
nd
 exon, transcription of this gene can be 
initiated and give rise to mRNA. This RNA cannot be processed by splicing because of the 
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lack of a splice acceptor (that was deleted together with the major part of the 2
nd
 exon; Figure 
2.16). Theoretically, its size is 3,9 kb. This was analysed with RT-PCR using intron- and 3’-
end specific primers. The PCR product was found only in NRF-KO cells (Figure 2.30), 
correlating with the existence of the non-spliced form of the NRF mRNA in these cells. Thus, 
an mRNA is synthesized in NRF-KO cells that contains the 1
st
 exon (115 bp), the 1
st
 intron 
(1082 bp) and the distal part of the 2
nd
 exon (870 bp). With Northern Blot analysis using a 
labelled 2
nd
 exon specific DNA fragment no RNA band was detected in NRF-KO cells 
(Figure 2.17). This can be explained by a very low level of the intron-containing mRNA 
which might be due to its instability. Translation of NRF-KO mRNA into protein is 
unexpected because of multiple STOP codons in the intron part following right after the 1
st
exon.
Despite of the presence of a transcription product in NRF-KO cells no NRF protein was 
formed when tested with Western Blots using antibody directed against the C-terminus of the 
NRF which is encoded by the 3’-end of the NRF gene and is homologous to the NRF-KO 
mRNA (Figure 2.18). The presence of the peptide corresponding to the 1
st
 exon of the NRF 
gene could not be tested. Because of the very small size (38 amino acids) a biological function 
of such a peptide is not very probable, but cannot be excluded. At least it would lack the so far 
defined functional domains of the NRF. Thus, a deletion of the NRF in NRF-KO samples and 
with this the generation of NRF-deficient mice could be confirmed.  
NRF-KO mice are viable, appear phenotypically normal and exhibit normal life spans. It is 
demonstrated that NRF does not fulfill an essential function in mouse development or adult 
life. There are two possible explanations for this observation. First, NRF acts in NF-NB
inducible promoters regulating genes involved in a variety of cellular processes. Most of the 
NF-NB regulated genes are silent in the constitutive situation. Upon extracellular stimulation 
these genes become activated and give rise to a rapid response. The best characterized 
promoters containing NRF binding sites are those of the cytokines IFN-E, IL-8 and iNOS. All 
these proteins in already low doses modulate serious biological effects and are therefore very 
tightly controlled. It seems, that NRF is not the only factor inhibiting the constitutive 
expression of these genes and that the absence of NRF can be successfully compensated by 
other factors. Dysregulation of the NF-NB system was shown to be involved in acute and 
chronic inflammatory processes as well as in cancer (Baldwin et al, 2001). Many human 
leukaemia’s and lymphomas show constitutively active NF-NB in the nucleus. Also, the 
constitutive activation of the NF-NB pathway is often associated with inflammatory diseases, 
such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and asthma. The 
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elevated levels of NF-NB are accompanied by enhanced recruitment of inflammatory cells and 
the production of pro-inflammatory mediators. Although it is unclear whether increases in 
pro-inflammatory cytokine production are the cause or the result of NF-NB activation, 
constitutive NF-NB activity could be caused by defects in the regulatory mechanisms that 
control NF-NB activation. NRF is not the only factor preventing constitutive expression of 
NF-NB inducible genes. We assume that other regulators can functionally compensate NRF 
deficiency in NRF-KO mice. Such kind of a compensatory mechanism was already shown to 
exist in the NF-NB system. The activity of NF-NB is controlled at multiple levels. 
Extracellular signals activate degradation of the cytoplasmatic NF-NB inhibitor complex of 
INB proteins and allows the translocation of NF-NB from the cytosol to the nucleus. The INB
proteins include INBD, E, J, H, and ]. Analysis of mice deficient in INB members demonstrates 
that hyperactivation of NF-NB signaling has a dramatic impact on lymphopoiesis. Mice 
deficient in INBD die about 10 days after birth and appear immunodeficient with extensive 
inflammatory dermatitis and secondary granulocytosis, due to a constitutive NF-NB activation 
(Beg et al, 1995). In contrast, INBH-deficient mice exhibit a mild immunological phenotype, 
but demonstrate an upregulation of INBD and INBE, suggesting that INB members functionally 
compensate for each other (Memet et al, 1999). This hypothesis was confirmed through the 
generation and analysis of mice deficient in both INBD and INBH. In contrast to single  INBD
or INBH mutants, double mutant mice die at birth, lack mature B and T cells and their 
lymphocyte precursors exhibit increased apoptosis due to NF-NB hyper-activation (Goudeau 
et al, 2003). The same is true for differentiation of NK cells. Neither INBD nor INBH-
deficiency have major effects on NK cell generation, while their combined absence leads to 
NF-NB hyper-activation, resulting in reduced NK cell numbers, incomplete NK cell 
maturation and defective IFN-J production (Samson et al, 2004). The fact that the NF-NB
system is redundant in its regulation highlights its biological importance and supports the 
hypothesis of NRF compensation. 
Members of the INB family of proteins keep NF-NB in the inactive form in the cytoplasm, but 
some level of the NF-NB proteins is present in the nucleus also in the unstimulated state. In 
this study we could confirm this fact testing nuclear extracts isolated from unstimulated cells 
with electromobility shift assays using an NF-NB specific probe (Figure 2.20). NRF acts on 
NF-NB silencing in the nucleus and does it by binding to the negative regulatory element 
(NRE).
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Proteins that collaborate with NRF in the nucleus or compensate NRF absence are still to be 
identified. However, a number of repressor elements were recently described in the promoters 
of cytokine genes, similarly regulated by NF-NB. In the IL-1E promoter a novel negative 
element was identified that was suggested to play a role in suppressing its constitutive activity 
(Lebedeva et al, 1997). The promoter of the IL-6 gene contains a binding site for the 
mammalian transcriptional repressor RBP (CBF-1), which binding represses IL-6 activation 
(Vales et al, 2002). Despite a common function on the constitutive inhibition of NF-NB
regulated promoters no apparent homology was found between these published sequences and 
NRE (table 3.1).
 Sequence 
Found in 
promoters
References
NRE AATTCCTCTGA IFN-E, ѽҏiNOS, IL-8 Nourbakhsh, 1999
negative element in IL-1E promotor AATATT IL-1E Lebedeva T., 1997
RBP binding site TTTCCCATG IL-6 Vales L., 2002 
Table 3.1. Sequence comparison of the negative elements in cytokine promoters. 
IFN-E, iNOS, IL-8 similarly to IL-1E and IL-6 are not constitutively expressed in healthy 
tissues. Uncontrolled production of these cytokines may be harmful and contribute to 
pathological inflammatory processes. This is one of the reasons why regulation of cytokine 
genes has to be tight. And there is no evidence that different NF-NB inhibitory factors cannot 
replace one another in the case of functional inactivity of one of them, as for example, in the 
NRF-KO situation. This question is still to be addressed as well as the possible existence of 
additional repressing factors that can share their function with the known ones. 
Murine NRF, similarly to the human homolog, is located in nucleoli. This is a cellular 
compartment where ribosomal RNAs processing and their assembly into ribosomes takes 
place. Analysis of the NRF protein showed that NRF can bind dsRNA (Niedick et al, 2004). 
The biological significance of nucleolar localization and RNA binding remains to be 
investigated. A classical example of a dsRNA-dependent protein is protein kinase PKR. PKR 
is an IFN-inducible gene that plays a role in antiviral host defense (Meurs et al, 1990). 
Following interaction with dsRNA, PKR becomes autophosphorylated and in turn 
phosphorylates target substrates, the best characterized being the D subunit of eukaryotic 
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protein synthesis initiation factor 2 (eIF2D) (Panniers and Henshaw, 1983). Moreover, PKR 
may provide a crucial first line of defense against certain types of viral infection by delaying 
the production of progeny virions through the inhibition of viral mRNA translation prior to 
the induction of IFN (Balachandran et al, 2000). In addition to this role, PKR has also been 
reported to function in a variety of signaling pathways, including those of dsRNA and NF-NB
(Yang et al, 1995; Der et al, 1997; Kumar et al, 1997; Chu et al, 1999). Despite this evidence, 
mice lacking the PKR gene do not exhibit any significant pathology. Regarding immunity to 
viral infection in these mice it was shown that PKR deficient mice are predisposed to lethal 
VSV infections and display an increased susceptibility to influenza virus infection 
(Balachandran et al, 2000). Besides its ability to bind dsRNA it has been shown that NRF acts 
through DNA:protein interaction, binding to DNA (NRE), as well as protein:protein 
interactions (Nourbakhsh and Hauser, 1999). Whether all these functions are responsible for 
the constitutive repression of NF-NB regulated promoters or if NRF participates in infection, 
in the regulation of cellular responses remains unclear. A challenge of the NRF deficient mice 
with different bacterial and viral agents can clarify the question of the participation of NRF in 
the defence reaction of the immune system. In the case of a pure inhibitory role of the NRF 
the NRF-KO mice should be more resistant towards infection. However, when the NRF has a 
co-stimulatory function as well, some disturbance in the mechanisms of host defense is 
expected. Many immune responses are pathogen-type dependent. As mentioned above host 
response of the PKR deficient mice to a number of viruses including vaccinia virus were 
described as normal (Yang et al, 1995; Abraham et al, 1999) and this is in contrast to an 
increased susceptibility of these mice to VSV and influenza virus (Balachandran et al, 2000). 
In mice lacking a functional IFN-D/E receptor immune responses to a series of viral infections 
(Vaccinia virus, LCMV, VSV, Semliki Forest Virus) are impaired, whereas the resistance to 
L. monocytogenes infection is normal (van den Broek et al, 1995). Thus, additional studies 
are needed to elucidate a role of the NRF in host defense. In particular, in vivo infections of 
NRF deficient mice with series of different pathogens are needed. 
3.2 Establishment and characterization of cells lacking NRF expression
For investigations on NRF function in vitro, NRF-KO cell lines were established. First, by in
vitro excision of the NRF flanked cassette ES cells lacking the NRF gene were produced. 
These NRF-KO ES cells were then used for generation of differentiated endothelial cells by in
vitro differentiation. Using an earlier published protocol (Balconi et al, 2000) a population of 
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differentiated endothelial cells was obtained. For selective immortalisation of endothelial cells 
Polyoma virus middle T antigen (PymT) was used. Mice transgenic for the PymT oncogene 
show vascular tumors (Bautch et al, 1987) and retroviral constructs with PymT transform 
murine endothelial cells in vivo and in vitro (Williams et al, 1988). PymT, a membrane-
associated protein, recruits and activates Src family tyrosine kinases, and once tyrosine is 
phosphorylated, binds proteins with PTB and SH2 domains such as ShcA, 
phosphatidylinositol 3-kinase (PI3K) and phospholipase CJ-1 (PLCJ-1). PymT mimics 
activated receptor tyrosine kinases by forming a ShcA-Grb2-Gab1 complex that is critical for 
endothelial transformation (Siew Hwa Ong et al, 2001). Therefore, endothelial cells show a 
greater susceptibility to transformation with PymT as, for example fibroblasts, which require 
the expression of a second oncogene in addition to PymT for transformation (Rassoulzadegan 
et al, 1982). Although the cells described in chapter 2.3 do not have typical endothelial 
morphology they express endothelial specific markers like CD34 (Figure 2.15). Despite 
specific effects of the PymT on endothelial cells a homogenous population of endothelial cells 
could not be obtained. It is proposed that for elimination of non-endothelial cell types further 
culture of the PymT infected cells is needed.  
Two other types of primary cell culture were used for further molecular studies: murine 
fibroblasts and macrophages isolated from NRF-KO mice. It was proposed that the absence of 
NRF causes some level of constitutive activation of the promoters in which regulation NRF is 
involved. Fibroblasts known as a major producer of IFN-E were analysed for constitutive 
expression of this cytokine. Macrophages were tested with respect to the activation of the 
iNOS promoter. Neither fibroblasts nor macrophages had acquired the expression of the tested 
cytokine genes in the non-induced state. Upon induction (NDV for fibroblasts and LPS for 
macrophages) both cell types reveal normal regulation and expression levels of IFN-E and 
iNOS, respectively (Figures 2.22 and 2.24). Unfortunately, the situation in cell culture does 
not always reflect activities in the whole organism. The two cell types examined here are only 
components of the complex immune response machinery. We have not examined the effects 
of NRF absence on other cells of the immune system, although NF-NB plays essential roles in 
the maturation and differentiation of T and B cells. Moreover, these cells show some 
constitutive NF-NB activity in certain maturation stages.  
Since NRF is expressed already during embryogenesis (Schwarzer, 2001) it is suggested that 
NRF deletion in the early stages is developmentally compensated. To examine this 
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compensation process a method for gene deletion in primary cells was established. Efficient 
retroviral infection was used for transduction of primary cells. Cells homozygous for the 
NRF-flox allele were infected with virus carrying a gene encoding Cre recombinase. Upon 
Cre action the flanked NRF gene was excised giving rise to NRF-KO cells. The use of Cre 
bearing retrovirus for deletion of the flanked cassette in cultured cells was already applied in 
previous studies (Silver et al, 2001). But in the current work some modifications were 
undertaken. First, Cre was fused to GFP protein. This allows to isolate cells that have 
undergone Cre mediated gene excision latest 72 hours after infection. Because of the long 
duration and toxicity of commonly used drug selection the advantage GFP-Cre fusion protein 
is especially useful for studying of rapid effects caused by the gene deletion. Secondly, in 
contrast to other studies this work was carried out on cell culture of freshly isolated primary 
cells. It was shown that GFP-Cre encoding retrovirus can be successfully used for sudden 
deletion of the flanked gene in primary cells. Although the infection of primary cells was not 
as efficient as of NIH3T3 cells, sorting of GFP positive cells resulted in a homogenous 
population of cells that had undergone gene excision. These KO cells were further propagated 
and analysed. Primary fibroblasts carrying the NRF-floxed allele were subjected to this 
procedure. The expression of the IFN-E gene in NRF-KO cells was analysed. Unfortunately, 
no constitutive activation of the IFN-E upon sudden deletion of the NRF was detected. Thus, 
deletion of the NRF alone (early in embryogenesis or sudden in adult cells) does not provoke 
an induction of the IFN-E promoter. This is in contrast to previous study where NRF was 
inactivated using NRF antisense RNA (Nourbakhsh and Hauser, 1999). This discrepancy can 
be explained by 1) a difference in the time course between Cre-mediated deletion of the NRF 
and the activation of the IFN-E gene, and 2) specific properties of the tested cells, as for 
example, some increased level of NF-NB in the nucleus of the human HeLa cells (these cells 
were used for antisense experiments) versus normal levels of NF-NB in the fibroblasts used in 
this study. Data of the current study indicates the presence of one or more factors that function 
on the inhibition of basal activity of this cytokine to compensate the lack of NRF.  
3.3 Effects of NRF deficiency and protein overexpression on the gene expression pattern 
To determine candidate genes which expression is affected by changes in the NRF expression 
an expression profiling was carried out. This assay can also help to recognize genes that 
indirectly interact with or are regulated by NRF. To reveal thorough information from this 
assay cells lacking NRF expression as well as NRF overexpressing were analysed. The 
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numerous genes which expression was somehow affected were organized in 10 clusters. Each 
cluster contains genes with similar expression pattern. Since regulated genes belong to 
different groups and are involved in various cellular processes no direct influence of NRF on 
a defined pathway could be found. Even genes participating in cell metabolism were amongst 
the regulated genes. Analysis of the expression patterns revealed some interesting facts: 
1) There are genes which expression is affected by NRF deficiency. This effect includes 
both up- and down-regulation of genes. 
2) There are genes affected only by sudden excision of the NRF gene. The expression of 
these genes in developmentally produced NRF-KO animals is similar to the level of 
their expression in WT cells. In this way regulated genes are schematically presented 
on the Figure 2.37. Cluster B groups the genes which expression was down-regulated 
upon sudden deletion of the NRF. While in the cluster H genes are collected that were 
induced by the sudden NRF knock-out. This let us confirm that there must be some 
adaptive activity which serves to compensate the deletion of the NRF gene when 
deletion occurs during early stages of embryogenesis. Adult cells are not competent 
any more for this kind of adaption.  
3) NRF overexpression also has both, inducing and repressing effects on the different 
genes (Figure 2.37; sample 4, clusters C, E and I). 
Detailed investigation of genes and signalling pathways involved in the compensatory process 
is matter of future work. An analysis of genes affected by the expression of the NRF let us 
propose a role of this protein in the regulation of apoptosis. In this model NRF deficiency is 
associated with reduced apoptosis, as a result of inhibition of CytC and caspase3 genes and 
induction of the apoptosis inhibitor Mdm2, while NRF overexpression leads to up-regulation 
of the some proapoptotic genes like p53 (Figure 2.40). Involvement of the NRF protein in the 
regulation of apoptosis was already proposed previously (Schwarzer, 2001). It was shown that 
during day 12 in murine embryogenesis NRF is strongly expressed in the interdigital web. 
The first sign of NRF expression in this area was found at day 11,5 of embryogenesis, while 
from day 12,5 the expression was maximal. This stage of development is associated with the 
formation of the paws and separation of the digits as a result of directed cell death in 
interdigital space. Thus, it was speculated that strong NRF expression can be correlated with a 
high level of apoptosis. A current study tries to confirm this hypothesis. Thus, the molecular 
mechanism of NRF action in the apoptosis process is to be clarified. NF-NB that appears as a 
main subject of the NRF inhibitory action promotes cell survival by initiation of the 
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transcription of antiapoptotic genes, such as Bcl-2, cIAP1 and cIAP2 (Chen et al, 2000; Wang 
et al, 1998).
It was demonstrated that NF-NB has a critical role in cell cycle progression. The NF-NB
activity was elevated during the G0-to-G1 cell cycle transition in mouse fibroblasts (Baldwin 
et al, 1991). The link between NF-NB activation and the control of the cell cycle progression 
was also found in human HeLa (Bash et al, 1997), Jurkat (Perkins et al, 1997) and human 
glioma cells (Otsuka et al, 1999). The NF-NB binding sites were identified in the promoter 
region of the cyclin D1 gene (Joyce et al, 2001) that provides direct evidence of the 
involvement of NF-NB in cell cycle regulation. Cyclin D1 in association with cyclin-
dependent kinases (CDKs) promotes G1-to-S-phase transition through CDK dependent 
phosphorylation of pRb and activation of transcription factor E2F, which is required for the 
activation of S phase-specific genes. Elevated expression of the NF-NB family of proteins is 
associated with oncogenesis. It was shown that 1) c-Rel induces aggressive 
leukemias/lymphomas in chickens and transgenic mice (Gilmore et al, 1999); 2) inactivation 
of RelA protein in mice results in massive liver cell apoptosis (Beg et al, 1995) 3) few 
alterations in the structure and expression of p50/p105 subunit of the NF-NB have been 
reported in leukemias and lymphomas (Liptay et al, 1992). The possible mechanism of 
dysregulation of the NF-NB expression is an impaired function of NF-NB inhibitors. An 
important inhibitor of the NF-NB is INB. Recent analysis of many human tumors demonstrate 
persistant nuclear NF-NB as a result of defective INB activity. In this context it could be 
proposed that NF-NB inhibitors act as a tumor supressors to control the oncogenic activation 
of NF-NB. Moreover, there is evidence that suggest that overexpression of the NF-NB may 
prevent the efficiency of chemotherapy and lead to chemoresistance. It has been shown that 
the inhibition of NF-NB by PS-341 markedly increases the sensitivity of myeloma cells to 
chemotherapeutic agents (Berenson et al, 2001). Thus, inhibition of the NF-NB pathway using 
natural NF-NB inhibitors including NRF may represent a novel strategy and lead to successful 
therapy with existing chemotherapeutic agents. 
3.4 Summary and future perspectives 
In the presented work the study of the role and the function of the NRF was undertaken using 
a model of transgenic mice expressing mutant forms of the NRF protein. It was shown that 
lack of the NRF alone does not lead to constitutive activation of NRF regulated genes in 
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tested cells. It was proposed that because of the tight regulation of the cytokine genes, NRF 
deficiency must be compensated. Investigation of collaboratory partners of the NRF and the 
molecular mechanism of its inhibitory action is an important aspect of the future studies. 
While sustained cytokine overproduction that is typical for some diseases has detrimental 
effects, including cellular injury and apoptosis, understanding the mechanism of basal 
repression of the NRF target genes might lead to a new strategy for tumor therapy. 
To elucidate a full role of the NRF in the mechanism of the regulation of the immune-relevant 
genes immune defense of the mice lacking the NRF protein should be analysed. The NRF-KO 
mice will be challenged with different bacterial and viral pathogens. This work needs a big 
animal resource. Currently preparatory work for this kind of experiments is carried out. 
Analysis of efficiency of the immune response in NRF deficient mice will reveal whether 
NRF has only inhibitory function or it has as well any co-activatory role. This information 
will provide insights into the role of the NRF in the mechanism of the host defense. 
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4. Materials and Methods 
4.1 Chemicals
chemicals were supplied by the companies Amersham, Bayer, Biolabs, Biorad, BRL Difco, 
Gibco, Merck, Miles, Prenner, Roche, Pharmacia, Qiagen, Seromed, Serva and Sigma. 
Enzymes were purchased from Biolabs, BRL, Merck, Perkin-Elmer, Promega, Roche, Serva 
and USB. Antibodies were obtained from Pharmingen, Silenus, Dianova, Clontech and 
IBGRL. Oligonucleotides were purchased from the companies Gibco and MWG. DNA-
sequencing was done by DNA-synthesis-group of the GBF or by MWG. Radioactive 
chemicals were purchased from Amersham-Buchler. 
4.2. Mice 
Specific pathogen-free C57BL/6 mice (4 weeks old) were purchased from Jackson 
laboratories.
NRF-lox chimeric mice were generated at Mice&More laboratories (Hamburg) by injection 
embryonic stem cells from a strain 129/Ola embryonic stem cell line with a targeted mutation 
in the NRF gene into a C57BL/6 blastocyst. 
Identified chimeric mice were outcrossed to C57BL/6 for strain maintenance. 
Mice with a complete deletion of the NRF gene (NRF-KO) were produced by crossing the 
NRF-flox animals with expressing Cre recombinase K14Cre mice. 
NRF-lox and NRF-KO mice were maintained on a mixed C57BL6 x 129 genetic background. 
Animal colonies are kept in pathogen free conditions at the Animal Facility of the GBF. 
K14Cre mice were kindly provided by Dr. Hafner (Department of Experimental Immunology, 
GBF, Braunschweig).
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4.3. Eukaryotic cell culture 
Culture media and solutions:
All reagents were dissolved in “Millipore”-water and sterile filtrated (pore size of 2 µm).
Pen/Strep (100x): 1.212 g Pennicillin/200 ml (10000 U/ml)  
2 g Streptomycine/200 ml (10 mg/ml)  
to dissolve adjust to pH 7.0 with NaOH, stored at -20qC
PBS:  140 mM NaCl 
  27 mM KCl  
7.2 mM Na2HPO4
14.7 mM KH2PO4 (pH 6.8 - 7.0) 
TEP:  500 ml sterile PBS 
0.6 ml 0.5 M EDTA (final conc.: 6 mM) 
15-20 ml Trypsine (0.1 - 0.2%; depending on the activity)
Puromycin:  5 mg/ml in H2O, sterile filtered, stored at - 20qC
G418:  100 mg/ml in H2O, sterile filtered, stored at - 20qC
Hygromycin:   431660 U/ml (batch dependent), sterile filtered, stored at 4ºC 
HEBS (2x):  280 mM NaCl 
50 mM HEPES
1.5 mM Na2HPO4 (pH 7.1) 
Gelatin (2% Sigma, cell culture grade) 
Medium:   Dulbecco's modified Eagle's medium (Sigma) 
    RPMI 
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Cells:
ES- E14TG2a, strain 129/Ola
This is a derivative of one of several murine embryonic stem cell (ES) lines developed by M. 
Hooper in 1987 (Smith and Hooper, 1983). The cells are deficient in HGPRT (HPRT) and are 
resistant to 0.06 mM 6-thioguanine. The cells remain undifferentiated when cultured on 
feeder layers (embryonic fibroblasts). The cells spontaneously differentiate and form 
embryonal structures in the absence of a feeder layer. When injected into blastocysts, the cells 
can colonize the germline. 
Medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 
1.5 g/L sodium bicarbonate and 4.5 g/L glucose supplemented with 0.1 mM 2-
mercaptoethanol, 90%; fetal bovine serum, 10%. 
MEF- Murine Embryonic Fibroblasts 
For long-term culture and maintenance, pluripotent ES cells must be grown on feeder cells. 
We have used monolayers of mitotically inactivated primary embryonic fibroblast cells. 
These cells were prepared from mouse embryos on days 11.5-12.5 of embryogenesis. To stop 
proliferation  the cells were irradiated with 3000 rads of gamma irradiation. 
Mouse skin fibroblasts
Primary dermal fibroblasts were isolated from 2-day-old mice. Trunk skin was removed, 
washed 1x in antiseptic Betaisodona Solution, 1x in75% ethanol and then in sterile phosphate-
buffered saline (PBS) and incubated overnight at 4°C in 0.25% trypsin in order to strip off the 
skin at the dermo-epidermal junction. After this enzymatic treatment, the epidermis was then 
mechanically separated from the dermis, the epidermis was peeled off and discarded. The 
resulting dermis layers were treated with 0,15% Collagenase A for 30min at 37qC and then 
mechanically dissociated. The digested dermal cell suspension was filtered through a sterile 
150 µm stainless steel mesh filter to remove debris. Thereafter the cell suspension was 
centrifuged for 5 minutes at 1200 rpm to achieve a single dermal cell pellet. This cellular 
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pellet was suspended and cultured in DMEM supplemented with 10% FCS. The culture 
medium was changed every two or three days. 
Resident peritoneal macrophages
Mice were sacrificed and peritoneal macrophages were obtained by peritoneal lavage with 
cold phosphate buffered saline (PBS). 8 mL of sterile PBS was injected into the peritoneum 
and withdrawn. The cells from 2-5 mice were then combined, centrifuged at 1200 rpm and
pelleted cells resuspended in serum-free RPMI 1640 medium. The cells were then plated in 
plastic tissue culture dishes (Corning), incubated at 37°C for 2 h, and washed three times with 
PBS to remove unattached cells. Cells were cultured in RPMI 1640 medium supplemented 
with 10% heat-inactivated fetal calf serum. 
Cell lines:
NIH3T3 - embryonic mouse fibroblast cells, ATCC-CRL 1658 
LMTK- thymidine kinase-deficient mouse fibroblast cells (ATCC No. CCL 1.3) 
Mouse C243 cells – (Oie et al, 1977)
GP+E86 - ecotropic RV packaging cells (Markowitz et al., 1988) 
In vitro differentiation of ES cells 
The relevant steps of cell isolation and culture are indicated in Figure 2.12. ES cells were 
grown in the undifferentiated state either on a feeder layer of irradiated murine fibroblasts. To 
induce ES differentiation, LIF and feeder cell layers were omitted, and ES cells were cultured 
in the presence of a cocktail of endothelial cell growth factors. Cells formed embryoid bodies, 
which were then collected and disaggregated in a collagenase-DNase solution by gentle 
pipetting. Endothelial cell lines were then developed by direct infection with PymT carrying 
retrovirus.
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The culture medium of undifferentiated ES cells was DMEM with 10% FCS supplemented 
with 2 mmol/L L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 1000 U/mL LIF,
1 mmol/L sodium pyruvate, and 0.1 mmol/L MEM nonessential amino acid.
To initiate ES cell differentiation and EB formation, ES cells were briefly trypsinized and 
suspended in DME medium. Vascular differentiation was optimized by the addition of a 
growth factor cocktail to the culture medium: recombinant human VEGF (Peprotech Inc) was
used at 50 ng/mL, human FGF at 100 ng/mL. Cells were seeded in bacteriological Petri dishes 
(1.5x104 cells per 35-mm Petri dish) and cultured for 11 days, without further feeding, at 37°C 
in an incubator with 5% CO2 in air and 95% relative humidity. The cells formed EBs. EBs at 
E11 were collected and disaggregated by 1-hour incubation in 1.5 mg/mL collagenase A 
(Boehringer-Mannheim) in DMEM plus 5% FBS. After 50 minutes of incubation, 25 µg/mL
DNase (Boehringer-Mannheim) was added.
After EB disaggregation, the cells were immortalized by PymT. Cell immortalization was 
performed as following. 24 to 48 hours after seeding in 24-well plates (0.5 to 1x106 cells per 
well), the cells were incubated with 10
5
 puromycin-resistant colony-forming units of the 
retrovirus vector N-TKmT in 1 mL of complete medium per well in the presence of 8 µg/mL
polybrene (Sigma). The virus-containing medium was replaced 3 hours later with fresh 
complete medium. 72 hours later, PymT-infected cells were selected by adding the puromycin 
at 2,5 µg/mL. Fresh medium containing puromycin was replenished 3 times per week. 
Colonies of puromycin-resistant cells, were observed after 20 to 30 days. 
The culture medium of ES-derived endothelial cells was DMEM with 10% FCS, 
supplemented with 2 mmol/L glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 50 
µg/mL endothelial cell growth supplement (Sigma), and 100 µg/mL heparin (Sigma). 
4.4. Cell induction and cytokine detection 
Infection with NDV
Cell were washed 2x with DME medium without FCS before infection and then incubated 
with NDV containing (1:8000 dilution) DMEM without FCS for 1h at 37qC. After that cells 
were washed 3x with FCS containing medium and incubated in normal growth medium (10% 
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FCS) for futher 24h. Supernatants were then collected and tested in IFN-test. Cells were used 
for DNA isolation or discarded. 
IFN-test
The IFN concentrations in the cell culture supernatants were determined by an antiviral assay 
based on the inhibition of the cytopathic effect of vesicular stomatitis virus (VSV) on IFN-
sensitive LMTK
-
 cells (Dinter and Hauser, 1987). 
LMTK
-
 cells (1,3 x 10
4
cells in 100 Pl of DMEM containing 10% FCS) were plated per well 
in a 96-well plate. 24h later two-fold serial dilutions of test culture supernatants or a standard 
IFN-E were added. Following incubation for 24 h at 37qC, the supernatant of each well was 
aspirated. Each well then received 100 Pl of VSV suspension containing approximately 40 
plaque-forming units/ml. The plates were incubate at 37qC. Protection was evaluated at 24-48 
h postchallenge by visual examination. Remaining cells were then stained with 1% crystal 
violet.
Induction of macrophages with LPS
24h after plating macrophages were stimulated with LPS (from Escherichia coli, Sigma-
Aldrich) by incubation with indicated in each experiment concentration of LPS diluted in 
normal growth medium. 
Detection of NO production
Supernatants were collected from the induced and control cells and analysed. The 
accumulation of NO2, a stable product of NO metabolism was measured as an indicator of NO 
production. 100 Pl cell-free medium was incubated for 30 min with 100 Pl Griess reagent (1% 
sulfanylamine in 30% acetic acid, and 0,1% N-(1-naphthyl) ethylenediamine dihydrochloride 
in 60% acetic acid; 1:1, v/v; Sigma) at room temperature and the absorbance at 540 nm was 
measured in a microplate reader. The NO2 concentration was calculated from a standard curve 
of sodium nitrite. 
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4.5. Gene transfer methods 
Electroporation of ES cells
The day before transfection the ES cells were plated on 100 mm gelatin coated dishes. For 
electroporation, the cells were trypsinized, washed with PBS and centrifuged. The cell pellets 
were resuspended in 1ml PBS (up to 10
7
 cells) and pippeted into an electroporation cuvette 
together with 20 µg DNA. Electroporation was carried out at 220 V and 500 µF. After that the 
cells were plated on mitotically inactivated MEFs in ES growth medium. 
Transfection with calcium-phosphate
Stable transfection (according to Pellicer  et al., 1978): 
One day before transfection the cells are seeded in 6-wellsplate (2-5 x 10
4
 cells/ well). 4 hours 
before transfection fresh DME medium is put on the cells. 5 µg of the DNA to be transfected 
is suspended in 200 µl 250 mM CaCl2. The solution is added drop by drop to 200 µl 2x HEBS 
buffer under continuous vortexing. In this solution the DNA coprecipitates with the calcium 
phosphate solution for 5-10 min Then the precipitates are pipetted to the cells and 15 hours 
later the medium on the cells is replaced by fresh medium. 2 days after transfection selection 
of stably transfected cells is started. The cells are transferred to a 55 cm
2
 plate or a 75 cm
2
flask and are selected.. Medium exchange is done every 3 to 5 days. The selection is finished 
in general after 7-12 days. 
The concentrations used for each selective drug is dependent on the cell type and has to be 
tested in advance. In this work following concentrations were applied: 
G418 – 1000 µg/ml 
Hygromycin B – 0,2 µg/ml 
Puromycin – 2,5 µg/ml 
Transient transfection: 
The preparation of the precipitates is identical to the method described for stable transfection 
but in this case there is no need for a selection because the expression from the extra 
chromosomal DNA (circular plasmid) is measured. 
At day one after transfection the precipitates are removed by medium exchange. At day two 
the cells can be analysed for the expression of the transfected gene. 
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Retroviral infection of mammalian cells
Establishing virus producer cells: 
Ecotropic packaging cells GP+E86 were plated in the concentration 8 x 10
4
 cells / well of 
6wells-plate. On the next day these cells were transfected with retroviral plasmid using 
standard calcium-phosphate method. After 7-10 days of selection viral titer in the supernatant 
can be determined.
Infection:
Packaging cells with a relatively high titer (10
4
-10
6
 CFU/ ml) are seeded in such a way that 
they are subconfluent at the day of infection. Packaging cells with a much lower titer can be 
grown to confluency at the day of infection. The DME medium on the packaging cells is 
renewed on the day before infection (virus production medium). The production medium 
should stay on the producer cells for at least 24 hours. On the same day the cells are seeded 
which have to be infected in a concentration of 2 x 10
4
 cells / well of 6wellsplate. On the next 
day the supernatant (virus containing medium) of the producers is harvested, mixed with 
polybrene (8 µg/ml final concentration), filtered (0.45 µm filter) to eliminate cells in the 
supernatant and given to the cells for infection in wanted dilutions (in polybrene containing 
medium; polybrene increases the efficiency of the infection through a better virus uptake). 
24h later medium is changed to the normal growth medium. 
Titer assay: 
For the determination of the viral titer NIH3T3 cells are seeded into a 24-well plate (5000 
cells/well). On the next day dilutions of the virus containing medium up to 10
-6
 are added 
after the medium on the 24 wells was exchanged for polybrene containing medium. For an 
exact virus titer determination the number of producer cells per ml production medium should 
be counted. 24-48 hours after infection the medium is exchanged for selection medium: The 
appearing cell clones can be stained with crystal violet at day 7-12 after the infection.
Electrotransformation of DNA into E. coli
For the electrotransformation a mix of competent cells and DNA is exposed to a exponentially 
decreasing electric field with a very high start amplitude. The transformation efficiency is 
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situated at 10
9
-10
10
 transformants per µg of DNA depending on the quality of the 
electrocompetent bacteria. A 50 µl aliquot of competent cells is thawed at room temperature 
and put on ice. 1 µl of plasmid DNA or  ligation mix is added, mixed  thoroughly and this mix 
is pipetted into a sterile pre-cooled 0.2 cm electroporation cuvette. The cuvette is exposed to 
an electric field in a electro-transformation room. Pulse controller and gene pulser are set at 
2.5 kV, 25 µF and 200 ȍ. The time constant should range between 4 to 5 ms. Immediately 
after transformation 1 ml LB-medium is added to the cuvette. The transformed cells are 
shaken 30 min at 37qC and subsequently are plated out in different dilutions on agar plates 
containing the appropriate selection medium. 
4.6  DNA analysis 
Extraction of Genomic DNA 
A 1 cm mouse tail snip or cell pellet was incubated with 300 Pl lysis buffer containing 1 
mg/ml Proteinase K at 54°C overnight until tissue is completely digested. The lysats were 
spinned down at maximal speed for 30 minutes. The supernatant was transferred to a new 
tube. For DNA precipitation the equal volume of isopropanol was added and mixed by gentle 
invertion. The DNA pellet was obtained after centrifugation at 13000 rpm for 15 min. The 
DNA pellet was washed with 70% ethanol, dried and resuspended in TE buffer.
Lysis buffer:   50 mM Tris 
    0.4 M NaCl 
    100 mM EDTA 
    0.5 % SDS
Boiling prep method (according to Dan Cimbora, FHCR, Seattle, USA) 
This method is used for DNA isolation from E. coli. The major advantages of this method are 
the quick preparation and the high quality of the isolated DNA (based on ‘Boiling prep’ from 
Holmes and Quigley). 
STET:  8% sucrose 
0.5 % Triton 
50 mM EDTA 
10 mM Tris (pH 8) 
LTE:   10 mg lysozyme/ 1 ml TE 
7.5 M NH4OAc
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TER: 10 µg RNase A/ 1 ml TE  
From the clones that have to be screened 2 ml cultures (LB+Ampicillin) were prepared and 
incubated in Kapsenberg tubes overnight at 37qC. After transferring the probes in 2.2 ml 
Eppendorf tubes, they were centrifuged for 1 min at 5000 rpm. The pellets were resuspended 
in 500 µl STET buffer and per tube 50 µl LTE was added. After a short incubation of 2-3 min 
at RT the probes were heated for 90 sec in an Eppendorf thermomixer at 95qC. After 5 min 
centrifugation (14000 rpm) a pellet is formed, which can then be removed with a toothpick. 
Then 50 µl 7.5 M NH4OAc and 500 µl isopropanol are added; the mix is vortexed and the 
DNA is pelletted by centrifugation for 5 min at 14000 rpm. After drying for a short time the 
pellet is solved in 100 µl TER solution. For restriction analysis 5 µl is used.
Random priming with the "Redi-Prime DNA labeling system"
Labelling mix:  dATP, dCTP, dTTP, exonuclease free Klenow enzyme,  
    oligonucleotide primer (9-mer) 
For this labeling reaction a commercially available system of the company Armersham is 
used. The reaction mix is available as a freeze-dried pellet in an Eppendorf tube. First 2.5-100 
ng DNA probe in 45 µl sterile water is denatured at 95qC for 5 min and put on ice 
immediately. The DNA and 5 µl of Į[32P]dCTP are added to the labeling mix, vortexed 
thoroughly and incubated for 10 to 30 min at 37qC. To stop the reaction 2 µl of 0.5 M EDTA 
is pipetted to the mix. 
After labeling, the probe is separated from unincorporated nucleotides over a Sephadex G50 
column. For this purpose the ready to use stacked Micro-SpinTM G50 columns from the firm 
Pharmacia Biotech are used. The perfect packing of the column is reached by spinning the 
columns for 1 min at 2800 rpm. The labeling mix is put on the column and centrifuged 
through the column for 2 min at 2800 rpm. The labeled probe is denatured in a boiling water 
bath for 5 min, put on ice immediately and added to the hybridizing solution. 
Southern Blot Analysis
For Southern, 10 µg of genomic DNA was overnight digested with the appropriate enzyme 
and run on 0.7% agarose gels in TAE solution. DNA was transferred to positive charged 
Nylon membrane in 0,4M NaOH and cross-linked to the membrane by drying at 80qC for 2h. 
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Southern blot hybridisation was performed using standard techniques. Hybridizations were 
done in buffer consisting of 0,5 M NaxHyPO4, pH 7,2, 7% SDS and 2mM EDTA. 
The membrane has to be pre-hybridized for at least 30 min and then the denatured 
radioactively labeled probe is added to the tube and hybridization takes place overnight at 
68°C. After hybridisation the membrane is washed with the following set of washes:  
2x 5 minutes with  Wash buffer I:  40mM NaxHxPO4, pH 7.2
    1% SDS  
    2 mM EDTA 
1X, 20 minutes with  Wash buffer II: 40mM NaxHxPO4, pH 7.2
    0.1% SDS,  
    2mM EDTA 
3X, 10 minutes with Wash buffer III: 100 mM NaxHxPO4, pH 7.2 
2 mM EDTA 
The washes are carried out at 68qC while shaking. 
Re-hybridisation:
For rehybridization, the probe is eliminated by washing several times in 0.1% SSC/ 0.1% 
SDS at 95qC. To check if the probe is completely removed, the stripped blot is exposed again. 
Rehybridization is performed as described previously. 
Polymerase Chain Reaction (PCR)
The PCR is a method used for amplification of defined DNA fragment using specific primers 
(approx. 20 bp long) that recognize appropriate sequences in the leading and lagging strand of 
DNA. PCR will allow a short stretch of DNA to be amplified to about a million-fold so that 
one can determine its size, nucleotide sequence, etc. There are three major steps in a PCR, 
which are repeated for 30 or 40 cycles: 
1. Denaturation 
During the denaturation, the double strand melts open to single stranded DNA, all 
enzymatic reactions stop (for example: the extension from a previous cycle). 
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2. Annealing 
In this step primers anneal to the DNA and the polymerase can attach and starts 
copying the template. 
3. Elongation 
This is the ideal working temperature for the polymerase. The bases (complementary 
to the template) are coupled to the primer on the 3' side (the polymerase adds dNTP's 
from 5' to 3', reading the template from 3' to 5' side, bases are added complementary to 
the template)  
PCR reaction components: 
PCR polymerase Buffer 
dNTPs mix (25 mM each nucleotide) 
primer mix (25 pmoles/µL each primer) 
Taq DNA polymerase (1 Unit/25 µL)
genomic DNA template (100 ng/µL)
the reaction will be adjusted with water up to 50ul volume. 
PCR programm used for amplification of NRF fragments: 
First denaturing 94 o C  10 min 
Denaturing  94 o C  30sec 
Annealing  62qC   30sec 
Elongation   68qC   4 min 
Last elongation 68qC   10 min 
Afterwards the PCR products are run on 1% agarose gels. 
DNA-isolation from agarose gels with‘Qiaquick’ gel extraction kit
Under high salt conditions the DNA-agarose piece is melted at 50qC for 10 min The resulting 
solution is centrifuged for 1 min through a mini-column. In this step the DNA binds to the 
column matrix, while the agarose-salt solution is running through. The column is washed with 
an ethanol-containing buffer. The DNA is eluded from the column with 30 to 50 µl TE. 
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4.7 RNA analysis 
Isolation of total cellular RNA
Total cellular RNA was isolated using Trizol reagent. The cell were trypsinised, washed with 
cold PBS and spun at 1000 rpm at 4qC. 1 ml Trizol reagent was added to each cell pellet. The 
cells were mechanically lysed by passing the cell lysate several times through a pipette. 0.2ml 
chloroform per 1ml of TRIZol reagent was added to each sample. After vigorously mix and
centrifugation at 13000 rpm 15 min at 4qC two phases are separated: lower red phenol-
chloroform layer, interphase and colourless upper RNA phase. For RNA precipitation 
aqueous, upper clear RNA containing phase was transferred to a new tube, 0.5 ml isopropanol 
was added, mixed and centrifuged at 13000 rpm, 4qC for 15 min. RNA pellet was washed 
with 75% ethanol, air dried and redissolved in RNase-free water. 
The concentration of the RNA was determined by measuring the A260 of the final 
preparation. A solution whose A260 = 1 corresponds to approximately 40 µg of mRNA per ml. 
The ratio between the readings at 260 nm and 280 nm gives an estimate of RNA purity. An 
A260/A280 absorbance ratio in the range of 1.8 to 2.0 indicates a pure preparation of RNA. 
Purification of mRNA
The Dynabeads
®
 mRNA Purification Kit is based on the unique Dynabeads magnetic 
separation technology. The use of Dynabeads mRNA Purification Kit relies on base pairing 
between the poly A residues at the 3' end of most messenger RNA and the oligo dT residues 
covalently coupled to the surface of the Dynabeads Oligo (dT)25. Other RNA species lacking 
a poly A tail will not hybridise to the Dynabeads Oligo (dT)25 and are readily washed off. The 
mRNA is captured by the Dynabeads Oligo (dT)25 and washed thoroughly using a magnet 
(Magnetic Particle Concentrator, Dynal MPC
®
). The mRNA is eluted from the solid phase by 
using a low-salt buffer. As starting material for the purification of mRNA we are taking 75 µg
of total RNA. Initially the RNA should be heated to 65°C for 2 minutes to disrupt secondary 
structures. Annealing of the mRNA to the Dynabeads Oligo (dT)25 is carrying out in binding 
buffer by rotating on mixer for 3-5 minutes at room temperature. After that the tube is placed 
on the magnet and the supernatant is pipetted off. After two washes with washing buffer, the 
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mRNA is eluted in 10ul of 10 mM Tris-HCl by heating to 80°C for 2 minutes. Eluted mRNA 
is transferred to a new RNase-free tube and stored at -80°C.
Binding Buffer - 4 ml 
20 mM Tris-HCl (pH 7.5) 
1.0 M LiCl 
2 mM EDTA 
Washing Buffer B - 4 ml 
10 mM Tris-HCl (pH 7.5) 
0.15 M LiCl 
1 mM EDTA 
RT-PCR
RNA was reverse transcribed using the SuperScript™ First-Strand Synthesis System for RT-
PCR (Gibco). Total RNA (1-5 µg) was combined with oligo-dT primer mix, dNTP mix and 
H20 and preheated at 65
o
C for 2 min to denature secondary structures. To the mixture was 
then added 5x RT Buffer, 10 mM DTT and RNase inhibitor. After 2min incubation at 42qC
Reverse Transcriptase was added to the samples. The RT reaction was incubated at 42
o
C for 
50 min following by heating at 95
o
C for 5 min. To remove RNA complementary to the cDNA 
the samples were treated with 1 µl (2 units) of E. coli RNase H at 37C for 20 min. The cDNA 
can now be used as a template for amplification in PCR.  
A control experiment without reverse transcriptase was performed for each sample to verify 
that the amplification was not caused by any residual genomic DNA. The mRNA for GAP-
DH was examined as the reference cellular transcript in each PCR reaction. 
Northern blot analysis
Northern blotting is a method for RNA analysis. Especially significant is to study how cells 
express different levels and types of mRNA. In this method RNA is loaded on denaturing 
0.8% agarose gels containing 1.2% formaldehyde and run overnight by 26 V. Next, the RNA 
is transferred onto a nylon membrane by capillary action in highly concentrated salt solution 
10xSSC. Once transferred, the RNA should be covalently cross-linked onto the membrane, by 
heating at 80qC for 2h. Detection of a specific mRNA in the total RNA sample is done by 
hybridization of the Blot with a specific, complementary radiolabelled DNA probe overnight 
at 65qC. This hybridization step followed by autoradiography. 
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Agarose gel :   1.2 g agarose,  
10 ml 10×MOPS buffer,  
18 ml formaldehyde (12,3M) 
10×MOPS buffer: 200 mM MOPS, 
50 mM Sodium acetate, 
10 mM EDTA, pH 7.0 
Running buffer :  100 ml 10×MOPS buffer 
Hybridization buffer:  10% Dextransulfat 
 1% SDS 
 1 M NaCl  
 0,5 mg/ml Yeast-RNA 
 0,5 mg/ml salmon sperm DNA  
5×GLB:    16 µl bromophenol blue (1mg/ml), 
80 µl 500mM EDTA, pH 8.0,  
720 µl formaldehyde, 
2 ml 100% glycerol, 
3084 µl formamide 
4 ml 10×MOPS buffer 
Post-hybridization washes were done as follows: 
2x, room temperature, 20 minutes, 2x SSC/1% SDS  
1x, 65° C, 20 minutes, 2x SSC/0.5% SDS  
1x, 65° C, 20 minutes, 0.1x SSC/0.1% SDS 
Gene expression analysis
Microarray hybridizations were performed by the Array facility, GBF, Braunschweig. 
Affymetrix GeneChip® Murine Genome U74Av2 arrays were used which consist of coated 
glass slides with series of oligonucleotide probes synthesized in situ. These arrays contain 
probes for functionally characterized genes and  EST clusters. Biotinlabeled cRNA probes 
were generated from each sample to be analyzed, starting form 5 µg of DNAseI-treated total 
cellular RNA, prepared as described above. The cRNA probes were individually hybridized 
on the arrays and the signals were detected according to the manufacturer’s instructions 
(Affymetrix). Hybridization data were analyzed using the MAS5.0 (Affymetrix) software. 
Genes were considered as significantly expressed in a given experiment, if they were 
classified as P (present), but not as M (marginal) or A (absent). 
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4.8 Protein analysis 
Preparation of nuclear extracts
Nuclear extracts were prepared using NucBuster Protein Extraction Kit (Novagen) and 
following manufacture protocol. After trypsinization of adherent cells the cell pellet was 
washed with PBS and NucBuster Reagent 1 was added (150 Pl per 50 Pl packed cell volume). 
After vortexing and 5 min incubation on ice the cell lysets were cetrifuged and supernatant, 
corresponding cytoplasmic fraction, was removed. The pellet were then resuspended with 
NucBuster Reagent 2 containing Protease Inhibitor Coctail and reducing reagent DTT. After 
additional vortexing and incubation on ice, the lysat was centrifuged. The supernatant – 
nuclear extracts was transferred to a separete tube and stored in aliquots at -80qC. The pellet 
left after nuclear protein extraction was used for additional nucleolar protein extraction. 
BCA assay
This method was used for measurement of  the protein concentration. 
Reagent A:  1% Bicinchonin acid (BCA) 
0.16 M Na2CO3
7 mM Na-tartrate 
0,11 M NaHCO3
1 ml 1 N NaOH 
fill up to 100 ml with H2O; (pH 11.25) 
Reagent B: 4% CuSO4 x 5 H2O
Work solution: 10 ml reagent A + 0.2ml reagent B 
In a 96-wellsplate the wells of the first row are filled with 190 µl H20, in all other wells 100 
µl/well is added. In the first well of the first row (A1) 10 µl of Triton lysis buffer is pipetted, 
in A2 10 µl of reference protein solution (3 mg/ml lysozyme) are put and 10µl of each probe 
are added  to the first row. With a multi-channel pipette the solutions in the first row are 
mixed, then 100 µl per well removed and pipetted to the second row. This is continued up to 
row H and results in a 1:2 dilution for each row. The micro titer plates are incubated for 30 
min at 60qC and measured in the ELIZA-reader at 560 nm. From the reference data (column 
2) the protein concentration of the unknown probes can be derived immediately. 
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Electromobility Shift Assay (EMSA)
For electromobility shift assay the following oligonucleotides comprising NRF binding site 
were used:  
NRE forward  5’ AAT TCG AAT TCC TCT GAC GAA CA 3’ 
 NRE revers     5’ TGT TCG TCA GAG GAA TTC GAA TT 3’ 
As a control, double-stranded NF-NB consensus oligonucleotide (Santa Cruz) was used: 
  5’ AGT TGA GGG GAC TTT CCC AGG C 3’ 
  3’ TCA ACT CCC CTG AAA GGG TCC G 5’ 
The oligonucleotides were end-labelled with 
32
P- ATP by T4 polynucleotide kinase in the 
following reaction:   
1 Pl oligonucleotide (10pmol) 
    1 Pl 10x polynucleotide kinase buffer 
    1 Pl T4 polynucleotide kinase 
    2 Pl 32P- ATP (20uCi) 
    5 Pl  water 
The labelling reaction was carried out for 30min at 37qC. And then unincorporated 
nucleotides were removed with a Sephadex G50 columns.  
For annealing two complemented oligonucleotides were boiled for 5 min and then let slowly 
cool down to room temperature. 
DNA binding: 
Nuclear extracts (10 µg) were incubated for 30 min in binding buffer together with 1 x 10
5
cpm of labeled oligonucleotide.  
Binding buffer: 50 mM KCl, 20 mM Tris-HCl pH 7,8, 2 mM Mg acetate and 1 mM DTT. 
Samples were electrophoresed for 3 h on 5% polyacrylamide gels. Gels were dried and 
exposed to x-ray film for minimum 24 hours. 
Western Blot
10-30 Pg of protein per lane was separated on gradient 4-12% Bis-Tris gel (Invitrogen) and 
transferred by electroblotting onto nitrocellulose membranes (Amersham). The membranes 
were blocked in 5% non-fat dry milk dissolved in T-TBS (Tween tris buffered saline) (20 mM 
Tris/HCl, pH 7,5, 137 mM NaCl and 0,1% Tween-20). Immunoblotting was performed using 
monoclonal antibody directed against the Myc-tag (Roche) or polyclonal antibody directed 
against the 20 C-terminal amino acids of the NRF protein. Filters were then incubated with 
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the secondary horseradish peroxidase conjugated anti-mouse or anti-rabbit antibody. Proteins 
were detected using an enhanced chemiluminescence protein detection method (Pierce). 
Immunofluorescence
Cells were plated onto 24 mm diameter round coverslips and fixed with cold (-20qC)
methanol/acetone (1:1) for 5 min. After fixation, cells were washed 3 times with PBS 
containing 3% bovine serum albumin (BSA). The cells were incubated for 1 h at room 
temperature with the primary antibody (anti-Myc-tag or anti-NRF) at 1:250 dilution. Excess 
antibody was removed by washing 3 times with PBS containing 1% saponin. The cells were 
then incubated for 45 min at room temperature with fluorescent-labeled anti-mouse or anti-
rabbit IgG antibody (Dianova) at 1:800 dilution. After washes with PBS 0,1% saponin cells 
were mounted onto glass slides with Elvanol and analysed. 
Fluorescence Flow Cytometric Analysis
Fluorescence flow cytometric analysis was performed by a FACStar Plus apparatus (Becton-
Dickinson & Co). Cells were detached by trypsin treatment. A cell suspension (500 µL) in 
PBS supplemented with 2% FCS was incubated with mAbs to be tested for 30 minutes at 4°C. 
Cells were then washed twice in PBS containing 2% FCS. The second incubation was carried 
out at 4°C with the use of FITC-conjugated goat anti-rat IgG (50 µg/mL, Jackson Immuno
Research Laboratories, Inc). After 30 minutes, the cells were washed 3 times in PBS with 2% 
FCS and then analyzed.
Fluorescence Activated Cell Sorting (FACS)
This method was used to assess GFP expression by transfected cells. The cells to be tested 
were harvested (typically from well of 6-wellsplate plate), washed 1X with FACS buffer (1X 
PBS 2% FCS), spun at 1000 rpm for 5 min, resuspended in 500ul FACS buffer containing 
10ug/ml propidium iodide to exclude dead cells and analyzed 
Quantifying FACS Data: 
FACS data collected by the computer can be displayed. The X-axis plots the intensity of 
green fluorescence. The individual black dots represent individual cells.
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5.1 Plasmids and oligonucleotides
Existing plasmids that were used
muNRFtar -     M.Schwarzer, PhD thesis, 2001 
pNRFrepaired -    I.Niedick, PhD thesis, 2004  
pNRF(fl)-GFP -   I.Niedick, PhD thesis, 2004 
pBS500 -     S.Gagneten at el, 1997 
pM5ENRFN –    A. Otto, RDIF, GBF 
N-TKmT  -    Williams, 1988; Koblizek, 1997  
(PymT expressing retrovirus) kindly provided by Dr. Deutsch (University of Münster) 
Plasmids cloned during the current work
pM5GFPCreneo -  retroviral vector carrying a 5’ MPSV-LTR controlling a GFP-CRE 
fusion protein, followed by a Polyo-IRES element controlling a neo
gene and terminated by a 3’ MPCV-LTR (figure 2.25). 
pM5mycNRFgtn -  retroviral vector carrying a 5’ MPSV-LTR driving expression of a myc-
tagged NRF protein, followed by a Polyo-IRES element controlling a 
gfp-tk-neo gene and terminated by a 3’ MPCV-LTR (figure 2.33).  
pM5mycNRFgfp -  identical to pM5mycNRFgtn but with exchange of  gfp-tk-neo gene to 
eGFP gene. 
Oligonucleotides
NRF 3’-end: 5’ CTG AGA TAG GCT CCC GTA TGC CC 3’ 
NRF 5’-itr:   5’ GTC TCT GGT ATA GCC TTA GTA GTG GG 3’ 
NRF 3’-out:  5’ GTG ATG AGT GAC AGA GTC TGC TCC C 3’ 
Neo:             5’ CCG CTT CCT CGT GCT TTA CGG 3’ 
IFNB_sense: 5’ CAT CAA CTA TAA GCA GCT CCA 3’ 
IFNB_antisense: 5’ TTC AAG TGG AGA GCA GTT GAG 3’ 
GAPDH_sense: 5’ ACC ACA GTC CAT GCC ATC AC 3’ 
GAPDH_antisense: 5’ TCC ACC ACC CTG TTG CTG TA 3’ 
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5.2 Abbreviations
D   alpha 
aa   amino acid 
AB   antibody 
ATG   translation start codon 
ATCC   american type culture collection 
ATP   adenosintriphosphate 
E   beta 
bp   basepare 
cDNA   complementary DNA 
CFU   colony forming units 
Ci   Curie 
CMV   cytomegalovirus 
Cre   cyclization recombination 
Da   Dalton 
DBD   DNA-binding domain 
DME   Dulbecco’s Modification of Eagle’s (medium) 
DNA   desoxyribonucleic acid 
DnaseI   desoxyribonuclease 
dsRNA  double-stranded RNA 
DTT   dithiotriotol 
EB   embryonic body 
E. coli   Escherichia coli 
env   envelope gene 
ES (cells)  embryonal stem cells 
FACS   fluorescence activated cell sorting 
FCS   fetal calf serum 
FGF   fibroblast growth factor 
FITC   fluorescein isothiocyanate 
J   gamma 
GFP   green fluorescent protein 
G418   aminoglycoside-2’-deoxystreptine (Gentamycin-derivative) 
h   hour 
HMGI(Y)  high mobility group protein  
HTLV-1  human T Cell Leukaemia Virus 
IFN   interferon 
IL   interleukin  
iNOS   inducible nitric-oxide synthase  
IRES   internal ribosomal enty site 
IRF   interferon regulatory factor 
ISGF   interferon stimulated gene factor 
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ISRE   interferon stimulated response element 
JAK   Janus-kinase 
kb   kilobase 
kDa   kilodalton 
KO   knock out 
loxP   locus of X-over (target sequence for the Cre recombinase) 
LPS   lipopolysaccharide 
LTR   long terminal repeat 
MEF   murine embryonal fybroblasts 
min   minute 
MLV   murine leukemia virus 
MOI   multiplicity of infection 
MPSV   myeloproliferative sarcoma virus  
mRNA  messenger RNA 
n.d.   not determined 
NDV   Newcastle Disease Virus 
neo   neomycin phosphotransferase 
NF-NB   nuclear factor kappa B 
NLS   nuclear localization signal 
NK   natural killer (cells) 
NRE   negative regulatory element 
NRF   NF-NB-repressing factor 
NO   nitric oxide 
NRD   negative regulatory domain 
OD   optical density 
PAGE   polyacrylamidgelelectrophoresis  
PBS   phosphate buffer salt solution 
PCR   polymerase chain reaction 
PKR   dsRNA-dependent kinase 
Polio   poliovirus 
polyA   polyadenylation signal 
PRD   positive regulatory domain 
PymT   polyoma-virus middle T antigen 
RNA   ribonucleic acid 
Rnase   ribonuclease 
rpm   rotations per minute 
RT   reverse transcription 
SA   splice acceptor 
SD   splice donor 
SDS   sodiumdodecylsulfate 
Stat   signal transducer and activator of transcription 
SV40   Simian virus 40 
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TGF   transforming growth factor 
TLR   Toll-like receptor 
TK   tymidine kinase 
TNF   tumor necrosis factor 
U   units 
VEGF   vascular endothelial growth factor 
VSV   vesicular stomatitis virus
WT   wild type 
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